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In cell metabolism, substrate channeling is a phenomenon where the product of 
one reaction is transported to a second enzyme active site without equilibrating into bulk 
solvent. Chapter 1 reviews the rationale and evidence for substrate channeling with the 
specific example of proline metabolism. Oxidation of proline to glutamate is catalyzed in 
consecutive reactions by proline dehydrogenase (PRODH) and pyrroline-5-carboxylate 
dehydrogenase (P5CDH). The intermediate Δ1-pyrroline-5-carboxylate reportedly tends 
to be labile and inhibitory towards several metabolic pathways.  
One of the main objectives of this dissertation was to investigate substrate 
channeling between independent proline oxidative enzymes from Thermus thermophilus- 
TtPRODH and TtP5CDH. Chapter 2 establishes that TtPRODH and TtP5CDH are 
capable of interacting with a dissociation constant (KD) of 3.03 µM as demonstrated using 
Surface Plasmon Resonance (SPR). As observed in the present study, this interaction is 
possible only with a specific orientation of TtPRODH relative to TtP5CDH. A docking 
model of the two enzymes predicts an orientation of the active sites which is supportive 
of substrate channeling. Corroborating observations are made with kinetic studies. We 
observe that interference of TtPRODH-TtP5CDH complex by catalytically inactive 
mutants TtPRODH R288M/R289M and TtP5CDH C322A lead to significant decrease in 
glutamate formation. The results pave the way for testing substrate channeling in 
eukaryotic enzymes. In chapter 3, two novel eukaryotic enzymes from Saccharomyces 
cerevisiae, Put1p (PRODH) and Put2p (P5CDH), have been characterized. Particular 
attention was focused on the oxidative half-reaction of Put1p for gaining insight into 
possible redox functions of human PRODH.  
Previous studies show that bifunctional enzyme from Gram-negative 
Bradyrhizobium japonicum (BjPutA) containing PRODH and P5CDH domains, exhibits 
substrate channeling via an elegant internal tunnel. BjPutA and its channeling variants 
were used to test the role of substrate channel in hydrolysis of P5C, an essential step in 
proline oxidation. These aspects of substrate channeling are discussed in chapter 4. 
Overall, this study provides an improved understanding of: (1) Substrate 
channeling in proline oxidation; and (2) a model for investigating substrate channeling 
between other individual enzymes that catalyze consecutive reactions.  
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CHAPTER 1 
 
Introduction: 
Substrate channeling in proline 
metabolism 
 
Note: This chapter has been published as a review article: “Substrate channeling in 
proline metabolism.” Arentson BW, Sanyal N, Becker DF. Front Biosci. 2012 Jan 
1;17:375-88.  Permission for usage in thesis obtained from Frontiers of Bioscience.   
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INTRODUCTION 
 It is well known that proline metabolism has important roles in carbon and 
nitrogen flux and protein synthesis. Proline metabolism has also emerged as a relevant 
pathway in other processes such as cell signaling, cellular redox balance, and apoptosis 
[1-3].  Proline homeostasis is important in human disease, where inborn errors in proline 
metabolism are thought to lead to neurological dysfunctions such as schizophrenia and 
febrile seizures, as well as errors in systemic ammonia detoxification and developmental 
disorders such as skin hyperelasticity [4-7]. Recently it was shown that mutations that 
disrupt proline biosynthesis are linked with progeroid features and osteopenia that are 
part of the autosomal recessive cutis laxa syndrome [8].  In bacteria and plants, proline 
metabolism is responsive to various environmental stresses such as drought, osmotic 
pressure, or ultraviolent irradiation leading to proline accumulation as a survival 
mechanism [9-11]. Overall proline has become a very important metabolite that is 
thought to be involved in many cellular processes. 
  Fundamental to understanding the roles of proline metabolism in various 
processes is knowledge of the relevant enzymes and mechanisms used to maintain proper 
proline homeostasis.  In this review, the unique aspect of substrate channeling in proline 
metabolism will be explored.  Insights into the channeling mechanisms of enzymes 
responsible for the catabolism and biosynthesis of proline are helping to reveal the many 
roles of proline within the cell. Here we review the structural and kinetic data that support 
substrate channeling of P5C/GSA and gamma–glutamyl phosphate in the proline 
catabolic and biosynthetic pathways, respectively. The data indicate that both 
intermediates are channeled which increases the efficiency of proline metabolic flux.  
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PROLINE METABOLIC ENZYMES 
Proline catabolism 
The catabolic and anabolic reactions of proline metabolism are shown in Figure 1. 
The catabolic pathway generates glutamate from the four electron oxidation of proline, 
which occurs in two catalytic steps [12].  In the first step, proline dehydrogenase 
(PRODH; EC 1.5.99.8) uses a flavin adenine dinucleotide (FAD) cofactor as an electron 
acceptor to remove two electrons from proline, rendering the intermediate ∆1-pyrroline-5-
carboxylate (P5C).  P5C then undergoes a non-enzymatic hydrolysis, which opens the 
ring structure and generates γ-glutamate semialdehyde (GSA).  Pyrroline-5-carboxylate 
dehydrogenase (P5CDH; EC 1.5.1.12) next pulls off two additional electrons from GSA 
using nicotinamide adenine dinucleotide (NAD
+
) to complete the conversion of proline to 
glutamate [12].   
The PRODH and P5CDH enzymes involved in the oxidation of proline are highly 
conserved in both eukaryotes and prokaryotes, but differ in whether they are fused into a 
bifunctional enzyme called proline utilization A (PutA).  As reviewed by Tanner, 
PRODH enzymes can be divided into three branches [13].  One branch consists of 
monofunctional enzymes, where the PRODH and P5CDH domains are found as separate 
enzymes. The other two branches have the PRODH and P5CDH domains on a single 
PutA polypeptide [13].  Originally it was thought that all prokaryotes contain bifunctional 
PutAs, and that all eukaryotes contain monofunctional enzymes. However, it is now 
known that Gram-positive bacteria contain monofunctional enzymes, thus limiting PutAs 
to Gram-negative bacteria [14].  
 
4 
 
 
 
 
 
Figure 1- Reactions of the proline metabolic pathway.  In the catabolic pathway, 
proline is converted to glutamate via a four electron oxidation process. Proline 
dehydrogenase (PRODH) performs the first oxidative step, resulting in the intermediate 
pyrroline-5-carboxylate (P5C).  P5C is subsequently hydrolyzed to glutamic 
semialdehyde (GSA), which is then further oxidized by P5C dehydrogenase (P5CDH) to 
generate glutamate.  In Gram-negative bacteria, PRODH and P5CDH are fused together 
on a bifunctional enzyme called proline utilization A (PutA). Proline anabolism begins 
with phosphorylation of glutamate by γ-glutamyl kinase (GK) to generate γ-glutamyl 
phosphate (gamma-GP). gamma-GP is reduced by γ-glutamyl phosphate reductase (GPR) 
to GSA , which cyclizes to form P5C.  P5C is then reduced to proline via pyrroline-5-
carboxylate reductase (P5CR).  In higher eukaryotes such as plants and animals, GPR and 
GK are fused together in the bifunctional enzyme pyrroline-5-carboxylate synthase 
(P5CS).    
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Figure 2 summarizes the domain organization of PRODH and P5CDH enzymes. 
Monofunctional PRODHs typically are 200-540 amino acid residues in length, while 
monofunctional P5CDHs are composed of 400-600 residues.  Thermus thermophilus 
PRODH and P5CDH are currently the only structures of monofunctional enzymes that 
have been solved (PDB IDs: 2G37, 2EKG, 2BHP, 2BJA) [14-16].  PutAs consist of 
1000-1350 residues with the P5CDH domain linked to the C-terminal end of the PRODH 
domain [13].  The two branches of PutA enzymes are distinguished by whether or not 
PutA also contains an N-terminal ribbon-helix-helix (RHH) DNA binding domain. PutAs 
that contain a DNA binding domain are trifunctional and are generally longer 
polypeptides than PutAs that lack a DNA binding domain [17-19].   
 
 
Figure 2-  Domain mapping of PRODH and P5CDH from E. coli (EcPutA), B. 
japonicum (BjPutA), and T. thermophilus.  In PutAs, the PRODH and P5CDH domains 
are connected by a linker region (L). Trifunctional PutAs such as EcPutA also have a 
DNA binding domain (D). TtPRODH and TtP5CDH are separate enzymes 
(monofunctional) in the Gram-positive bacteria, T. thermophilus. 
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Trifunctional PutAs act as transcriptional repressors—when cellular proline is scarce, 
PutA binds DNA and represses expression of the putA and putP (Na
+
/proline transporter) 
genes [20, 21].  Regulation of PutA is achieved through a functional switching 
mechanism, where the redox state of flavin determines whether PutA is bound to the 
DNA and acts as a transcriptional repressor or is peripherally bound to the membrane 
where it efficiently catabolizes proline [22].  
Recently, the first crystal structure of a complete PutA protein (Bradyrhizobium 
japonicum) was solved by Tanner’s group (PDB ID: 3HAZ). Previously, the only 
structures available for PutA were of the isolated PRODH and DNA binding domains. 
The PRODH domain structure was solved for PutA from Escherichia coli (PDB IDs: 
1K87, 1TJ2, ITIW, 1TJ0, 3ITG) [23-26], and the DNA binding domain of PutA was 
solved by solution NMR (Pseudomonas putida) and X-ray diffraction (E. coli) (PDB IDs: 
2JXG, 2GPE, 2RBF) [27-29]. These structures show that the PRODH domain is a 
conserved β8α8-barrel, while the P5CDH domain contains a well conserved Rossmann 
fold domain. The evolutionary divergence from bifunctional PutA to monofunctional 
PRODH and P5CDH is of interest due to substrate channeling between the active sites in 
bifunctional PutA. Substrate channeling between monofunctional enzymes would 
necessitate functional PRODH-P5CDH interactions, which have not yet been explored 
and are the focus of Chapter 2 in this thesis.   
Proline biosynthesis 
Proline biosynthesis from glutamate involves three enzymatic steps (Figure 1).  
The initial two steps are catalyzed by γ-glutamyl kinase (GK; EC 2.7.2.11) and γ-
glutamyl phosphate reductase (GPR; EC 1.2.1.41). GK uses adenosine-5’-triphosphate 
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(ATP) to generate γ-glutamyl phosphate, which is subsequently reduced by GPR using 
nicotinamide adenine dinucleotide phosphate (NADPH) to produce GSA [12].  GSA next 
cyclizes to P5C, which is a crossroads intermediate that, in principle, can be converted 
not only to proline, but also to ornithine or back to glutamate via P5CDH [12].  The 
reduction of P5C to proline is catalyzed by P5C reductase (P5CR; EC 1.5.1.2), while the 
production of ornithine from P5C requires ornithine aminotransferase (OAT; EC 
2.6.1.13), an enzyme that is important for balancing cellular nitrogen levels [12]. 
In bacteria and lower eukaryotes such as yeast, GK and GPR are discrete 
monofunctional enzymes.  In animals and plants, the GK and GPR domains are fused 
together into the bifunctional enzyme P5C synthase (P5CS) (Figure 3).  The GK and 
GPR domains are well conserved in lower eukaryotes and bacteria.  The GK domain is 
normally between 250-450 residues in length with an N-terminal amino acid kinase 
(AAK) domain. In bacteria, GK contains a C-terminal pseudo uridine synthase and 
archaeosine-specific transglycosylase (PUA) domain, which has no known function [30].  
It has been suggested, however, that the PUA domain may enable bacterial GK to have a 
gene regulatory role [31].  The structures of GK enzymes from E. coli and 
Campylobacter jejuni have been solved (PDB IDs: 2J5T, 2AKO) [32].  E. coli GK is 
composed of an N-terminal catalytic domain made up of eight nearly parallel β-sheets 
sandwiched by two layers of three and four α-helices.  It is connected by a linker region 
to the PUA domain, which contains a distinctive β sandwich [32].  
GPR typically contains 400-500 residues and consists of an N-terminal Rossmann 
fold domain for NADPH binding, a catalytic domain, and an oligomerization domain at 
the C-terminus [33]. The X-ray crystal structure of GPR from Thermotoga maritima  
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Figure 3-  Domain mapping of monofunctional γ-glutamyl phosphate reductase 
(EcGPR) and γ-glutamyl kinase (EcGK) enzymes from E. coli and bifunctional 
pyrroline-5-carboxylate synthase (P5CS) from Homo sapiens. M, putative 
mitochondrial signaling peptide, BD, binding domain for glutamate and ATP, O, 
oligomerization domain, and PUA, pseudo uridine synthase and archaeosine-specific 
transglycosylase domain with no known function in EcGK.  
 
reveals that the catalytic domain has an α/β architecture with a five-stranded parallel β-
sheet (PDB ID: 1O20) [33].  To date, no complete structure of bifunctional P5CS has 
been reported. However, the structure of the isolated GPR domain (PDB ID: 2H5G; 
unpublished) from human P5CS is available. The last enzyme of the proline biosynthetic 
pathway, P5CR, ranges from 400-500 residues in length and has a conserved N-terminal 
Rossmann fold for NADPH binding. Several crystal structures of P5CR have been 
determined including the human form (PDB ID: 2GRA) [34]. Human P5CR has an active 
site cleft made of an 8-stranded β-sheet sandwiched by α-helices on either side and 
oligomerizes to form a decameric structure of dimers [34].   
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INTERMEDIATES OF PROLINE METABOLISM 
The P5C/GSA and γ–glutamyl phosphate intermediates of proline metabolism are 
appreciably labile and reactive.  Figure 4 shows examples of undesirable fates that can 
occur with these intermediates. The instability of the intermediates implies substrate 
channeling may be important for maintaining efficient proline metabolic flux. The 
intermediate shared by the catabolic and biosynthetic pathways, P5C/GSA, has been 
shown to inhibit other enzymes, react with metabolites, and act as a signaling molecule. 
GSA has been reported to inhibit glucosamine-6-phosphate synthase from E. coli, 
cytidine 5’-triphosphate synthase, and the amidotransferase domain of carbamoyl 
phosphate synthetase [35-37].  Additionally, P5C forms adducts with other metabolites 
such as pyruvic acid, oxaloacetic acid, and acetoacetic acid [38].  P5C can also react with 
pyridoxal phosphate in patients with type II hyperprolinemia.  
 
Figure 4- Side reactions of intermediates pyrroline-5-carboxylate (P5C) and γ-
glutamyl phosphate (γ-GP).  (A) P5C can deactivate pyridoxal phosphate by forming an 
adduct, resulting in vitamin B6 deficiency in individuals with hyperprolinemia type II.  
(B) γ-GP can cyclize and dephosphorylate to form 5-oxoproline, which is suggested to be 
a neurotoxin in rats.  
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Type II hyperprolinemia is characterized by elevated plasma levels of P5C/GSA due to 
deficient P5CDH activity [39].  The high levels of P5C/GSA generates inactive adducts 
with pyridoxal phosphate, leading to lower amounts of functional vitamin B6 in patients 
(Figure 4) [38].  P5C also acts as a signaling molecule in eukaryotes and is thought to 
induce apoptosis by increasing intracellular reactive oxygen species [40, 41].  Altogether, 
it seems that controlling levels of free P5C/GSA would be beneficial.  
 The reactive intermediate in proline biosynthesis is γ–glutamyl-phosphate. The 
carbonyl phosphate group is susceptible to nucleophilic attack, resulting in the 
spontaneous cyclization of γ–glutamyl-phosphate into 5-oxoproline as shown in Figure 4 
[42, 43].  It has been suggested that 5-oxoproline is a neurotoxin. Interstitial injection of 
5-oxoproline into rats produces behavioral and neuropathological effects that resemble 
Huntington’s disease [44, 45].  The instability of γ–glutamyl phosphate seems to 
necessitate its channeling between GK and GPR during proline biosynthesis.  
OVERVIEW OF SUBSTRATE CHANNELING 
Rationale for substrate channeling 
Substrate channeling is a phenomenon where the product of one reaction is 
transported to a second active site without equilibrating into bulk solvent [46].  Three 
mechanisms of substrate channeling have been defined, two of which are reviewed by 
Miles et al. [47].  The most common form of substrate channeling occurs when a cavity 
exists within a protein that sequesters the intermediate from solvent, allowing for a means 
of travel between active sites [47].  To date, several enzymes are known to utilize these 
intramolecular tunnels, with the classic example being tryptophan synthase [48].  The 
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second form of channeling does not use intramolecular cavities; rather, electrostatic 
residues on the surface of the enzyme guide the intermediate from the first active site to 
the second active site [47].  Dihydrofolate reductase-thymidylate synthase complex 
stands as the common example for this form of channeling [49].  A third form of 
channeling exists in protein complexes such as pyruvate dehydrogenase, which uses 
cofactor lipoic acid to transfer substrate to multiple active sites using a swinging arm 
[50]. 
Substrate channeling has been proposed to be advantageous in the cellular 
environment for several reasons, as outlined by Ovadi and others [46, 51].  First and 
foremost it increases the efficiency of coupled reactions both by preventing the loss of 
intermediates to diffusion and by decreasing transit time between active sites. This allows 
the steady-state flux through the coupled steps to be attained more rapidly [46].  
Secondly, it prevents labile intermediates from decaying and reacting with other 
metabolites or enzymes within the cell [46].  Third, channeling segregates intermediates 
that may require a specific environment (e.g., pH) to retain structure or reactivity. 
Channels can provide an environment that facilitates an equilibrium step that normally 
would be unfavorable in the bulk solution. Finally, channeling limits intermediates from 
being siphoned out into competing reactions or pathways [46].   
All of the benefits listed above are not necessarily relevant for every channeling 
system. In the proline catabolic pathway, channeling of P5C/GSA may be most critical 
for making the hydrolysis of P5C to GSA more favorable at physiological pH values. The 
P5C/GSA equilibrium is highly pH dependent [35].  GSA is favored only below pH 6.5 
due to protonation of the pyrrolinium ring, which facilitates the hydrolysis of P5C to 
12 
 
 
 
GSA. Thus, one benefit of channeling between PRODH and P5CDH would be to 
increase the pKa of the pyrrolinium species above pH 6.6, making the hydrolysis of P5C 
to GSA more favorable at physiological pH conditions. If we only consider the P5C/GSA 
hydrolysis step, substrate channeling is likely more critical for the proline catabolic 
pathway than for proline biosynthesis, since P5C formation is favored at physiological 
pH. In the proline biosynthetic pathway, protecting the highly labile γ–glutamyl 
phosphate would be a clear benefit of substrate channeling between GK and GPR.  
KINETIC APPROACHES TO TEST FOR SUBSTRATE CHANNELING 
 Different strategies have been devised to examine whether channeling occurs 
between enzymes. Before reviewing the evidence for substrate channeling in proline 
metabolism, a short description of various experimental methods is described here. 
Transient time estimation 
A common strategy to test for channeling is to evaluate whether there is a lag time in 
reaching steady-state formation of the final product in a coupled assay. Figure 5 shows 
substrate (S) being converted to the final product (P) via the coupled action of two 
enzymes (E1 and E2). The lag time or transient time, Tau, is the time preceding the build-
up to steady-state formation of the final product using the substrate of the first enzyme 
[52]. If no channeling occurs, Tau should be equal to the ratio of Km/Vmax of the second 
enzyme. If the observed lag time is shorter than the Km/Vmax ratio, then it infers that the 
intermediate is transferred between the enzymes, E1 and E2. The extent of the observed 
lag time may vary among different channeling systems with a shorter transient time being 
interpreted as more efficient transfer or channeling [53]. Along with steady-state assays, 
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pre-steady state measurements can also be made to evaluate the lag time prior to product 
formation.  
Trapping the intermediate 
The effect of a reagent that specifically traps the intermediate species (I, Figure 5) 
on the kinetics of product formation can also be used to evaluate channeling. For 
example, o-aminobenzaldehyde (o-AB) which reacts with P5C to form a yellow complex 
can be used as a trapping agent for the PRODH and P5CDH coupled reaction. o-AB 
would be anticipated to decrease the overall rate of glutamate formation if no channeling 
occurs, while in a channeling system o-AB would have a negligible effect on the reaction 
kinetics.  Using a third enzyme that competes with E2 for the intermediate can also be an 
effective strategy to test for substrate channeling. 
Inactive mutants 
Another useful tool is to generate active site mutants of the two enzymes being 
studied (Figure 5B). In the case of suspected channeling partners, an active site mutant 
(e.g., E2) would be expected to compete with its native counterpart for interaction with 
the cognate enzyme (E1). If channeling occurs, adding the inactive E2 mutant in amounts 
excess to that of native E2 would decrease product formation. If no channeling occurs, 
adding the inactive E2 mutant to the coupled enzyme assay would have no effect on the 
rate of product formation. This strategy was effectively used to rule out channeling 
between aspartate aminotransferase (AAT) and malate dehydrogenase (MDH) [54]. 
If the channeling involves two enzyme active sites that are covalently linked, 
active site mutants can be used to generate a non-channeling control. Figure 5C illustrates 
that combining active site mutants of E1 and E2 creates a mixture of monofunctional 
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enzyme variants that can only generate product via a diffusion mechanism. The transient 
times of the native enzyme and the mixed enzyme variants can then be compared to 
distinguish between channeling and non-channeling mechanisms. This strategy was used 
recently to demonstrate channeling in bifunctional PutA [23]. 
 
 
Figure 5- Strategies for examining substrate channeling. (A) Transient time analysis 
of a coupled reaction involving two enzymes, E1 and E2, which convert substrate A into 
product C. A trapping agent can also be used to test whether intermediate B is released 
into bulk solvent during the reaction. (B) Inactivation of one of the enzyme pairs by site-
directed mutagenesis. If channeling occurs, adding inactive E2 would disrupt the active 
E1-E2 complex resulting in lower steady-state activity. (C) Testing channeling in 
bifunctional enzymes. Inactivation of the individual domains results in monofunctional 
variants that can only catalyze the coupled reaction via a diffusion mechanism. The 
mixture of monofunctional variants is thus a non-channeling control. 
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Designing fusion proteins 
Two active sites that are in close proximity can sometimes exhibit kinetic 
behavior that resembles direct channeling [55]. One strategy for distinguishing between 
active channeling and proximity effects is to change the relative orientation of two active 
sites, which is important for interacting enzymes [56]. A polypeptide linker can be 
engineered to covalently link the two enzymes with various degrees of flexibility and in 
different orientations [55]. If the enzymes are truly channeling, changes in the orientation 
of the active sites will have a dramatic effect on the kinetics of production formation. 
CHANNELING OF P5C/GSA 
The oxidation of proline to glutamate is catalyzed in consecutive reactions by 
PRODH and P5CDH (Figure 1). Avoiding release of P5C/GSA into bulk solvent during 
proline oxidation may be beneficial due to the chemical properties of P5C/GSA as 
discussed in the previous section.  Evidence for channeling P5C/GSA has recently been 
shown for bifunctional PutA from B. japonicum (BjPutA). Srivastava et al reported a 2.1 
Å resolution crystal structure of BjPutA (999-residue polypeptide) that reveals an interior 
channel connecting the PRODH and P5CDH active sites (PDB ID: 3HAZ) [23]. Figure 6 
shows a structural model of BjPutA, which purifies as a homodimer. Both PRODH and 
P5CDH domains contribute to the formation of the channel, with the two active sites 
separated by a distance of 41 Å. The connecting channel appears to start at the si face of 
the isoalloxazine ring of FAD and end at the catalytic cysteine (Cys792) of the P5CDH 
domain (Figure 6). Within the channel, the central cavity is lined by fifteen basic residues  
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Figure 6- Structure of dimeric BjPutA shown in ribbon representation. The PRODH 
domain (red) and the P5CDH domain (orange) of each protomer are connected by a 
linker region (green). Active site residues (Arg456, Cys792), FAD and NAD
+
 are 
displayed as sticks. -flap of each protomer is colored as magenta. The substrate channel 
of each BjPutA protomer is shown as blue surface. This model was made using PyMol 
[57] and PDB ID: 3HAZ. 
 
(Lys and Arg) and seventeen acidic residues (Glu and Asp), imparting a hydrophilic 
nature to the channel. Each of the PutA protomers has an individual channel connecting 
PRODH and P5CDH active sites. 
Interestingly, the dimeric structure of BjPutA seems to be critical for sealing the 
channel and minimizing access to bulk solvent. A beta-flap protrudes from the P5CDH 
domain (β strands, residues 628-646, 977-989) from one protomer and forms 
intermolecular interactions with the P5CDH domain of the second protomer (Figure 6). 
This β-flap is structurally conserved in Thermus thermophilus P5CDH (PDB ID 1UZB, 
residues 163-174,506-516) as well as a class I aldehyde dehydrogenase isolated from 
Catalytic
Arg456
Catalytic
Cys792
NAD+
-flap
FAD
Isoalloxazine
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sheep liver (PDB ID: 1BXS, residues 147-159, 486-498) [58] [16].  Thus, in BjPutA, the 
β-flap not only helps stabilize dimer formation but is also important for sealing the 
central cavity.   
Along with these structural features of channeling, kinetic evidence for 
channeling was also reported for BjPutA by Srivastava et al. Different experiments have 
provided strong evidence for channeling. First, the amount of P5C released into bulk 
solvent was estimated using o-aminobenzaldehyde (o-AB) as a trapping agent. P5C and 
o-AB react to form a yellow complex that can be monitored at 443 nm [59]. In the 
absence of NAD
+
, the P5CDH domain is inactive and leads to significant release of P5C 
into the bulk solvent, as detected by the yellow complex formation. In the presence of 
NAD
+
, however, the P5CDH domain is active, resulting in significantly lower o-AB-P5C 
complex formation, as the majority of P5C is converted into glutamate [23]. The apparent 
fraction of P5C that is channeled in BjPutA from PRODH to P5CDH was estimated to be 
0.7 by these measurements. 
 Substrate channeling in BjPutA was also examined by estimating the transient 
time to reach steady-state turnover of the second enzyme, P5CDH, using proline as a 
substrate [23, 60, 61]. With native BjPutA, steady-state formation of NADH (product of 
the P5CDH reaction) occurred without any apparent lag time [23]. The absence of a lag 
time in the approach to steady-state indicates substrate channeling. A non-channeling 
control was also analyzed using active site mutants of BjPutA that lack PRODH 
(R456M) and P5CDH (C792A) activity [23]. The R456M mutation inactivates PRODH 
but does not impair P5CDH activity, whereas the C792A mutation inactivates P5CDH 
but does not impair PRODH activity. The mixture of these monofunctional variants was 
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used as a non-channeling control as described above. In this non-channeling control, P5C 
formed by the C792A variant must diffuse out into bulk solvent and bind to the R456M 
variant before NADH is formed. In the assays with the non-channeling variants, a lag 
time of about seven minutes for NADH formation was observed [23]. The observed lag 
time was similar to the theoretical Tau value calculated from the independent PRODH 
activity and P5CDH kinetic parameters. An example of these steady-state assays is 
shown in Figure 7. Figure 7 illustrates the clear difference in the kinetic behavior of 
native BjPutA and the non-channeling control. With native BjPutA, NADH formation is 
observed without a lag time, while with the mixed variants a lag time of around 6.5 
minutes is observed. The results from these assays are consistent with a substrate 
channeling mechanism in BjPutA. Kinetic profiles of native BjPutA and the mixed 
variants were also compared by rapid-reaction kinetics under anaerobic, single-turnover 
conditions. Rapid mixing of native BjPutA and proline generated NADH with no 
apparent lag time. For the non-channeling variants, a 10 s lag time for NADH formation 
was observed after mixing the enzymes with proline.  These results show native BjPutA 
efficiently channels P5C/GSA.  
Evidence for channeling in PutA has also been reported from Salmonella 
typhimurium PutA (StPutA). Similar to EcPutA, StPutA contains the N-terminal DNA 
binding domain and is thus trifunctional.  Maloy et al demonstrated that the P5CDH 
domain shows a 14-fold greater steady-state production of NADH using P5C generated 
endogenously from proline by PRODH, as compared to exogenously added P5C [63]. In 
addition, they showed exogenous P5C was unable to compete against endogenous P5C.  
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Figure 7- Example of transient time analysis of BjPutA. Steady-state formation of 
NADH using proline as a substrate by native BjPutA (solid black curve) and an 
equimolar mixture of monofunctional variants R456M and C792A (solid grey curve). 
The mixture of the monofunctional variants serves as a non-channeling control. The 
dotted line represents the extrapolation used for estimating the lag-time. Native BjPutA 
shows no apparent lag in NADH formation, while a lag time of about 6.5 min is observed 
for the non-channeling control. The dashed line overlaying the grey curve of the non-
channeling control reaction was simulated using the kinetic parameters of PRODH and 
P5CDH as described previously and the following equation: [NADH] = v1t + (v1/v2)Km(e
-
v2t/Km
 - 1) [62]. Assays were performed at pH 7.5. 
 
Despite two-fold excess of exogenous P5C, 86 % of glutamate was produced from 
endogenous P5C.   Due to a lack of structural information on trifunctional PutAs, it is not 
clear whether a channel similar to that characterized in BjPutA exists. Future structural 
and kinetic experiments will need to be performed to fully address the channeling 
mechanism in trifunctional PutAs.  
CHANNELING OF GAMMA-GLUTAMYL PHOSPHATE 
As mentioned previously, channeling of the intermediate γ-glutamyl phosphate 
would be beneficial because of its instability. Channeling of γ-glutamyl phosphate is also 
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implicated by the fusion of GK and GPR in bifunctional P5CS. Kinetically speaking, data 
has existed for over forty years suggesting that a complex forms between bacterial GK 
and GPR in order to conceal γ-glutamyl-phosphate from solvent [64, 65].  A typical assay 
to measure GK activity is to add hydroxylamine along with the substrates, glutamate and 
ATP.  Hydroxylamine reacts with the product γ-glutamyl phosphate to make γ-glutamyl 
hydroxamate, which can be measured at 535 nm [64].  Multiple groups have documented 
that GK activity is dependent on the presence of GPR. GK is inactive or exhibits very 
low activity in the absence of GPR, suggesting GPR is required for GK activity [42, 43, 
64, 66, 67].  It was found that a 10:1 GPR:GK ratio was necessary to obtain maximal GK 
activity, indicating that a GK/GPR complex forms with excess GPR [66].  To test for a 
complex, Smith et al. tried incubating different ratios of bacterial GK and GPR, then 
looked for co-elution of the enzymes by chromatography [66].  Both proteins eluted 
separately meaning either a complex does not form or complex formation is transient and 
is dependent on substrate binding.  Other work suggesting a GK-GPR complex includes 
assays which contained GK and GPR, but lacked NADPH, the cofactor necessary for 
GPR activity [43].  In this case the GPR enzyme was inactive, but it still activated GK.  
GK has also been shown to be activated by incubation with GPR mutants, further 
demonstrating that GK activation by GPR does not require GPR activity [68]. Other 
experiments that have explored GK/GPR interactions include Chen et al, who created a 
mutant GK/GPR fusion protein that was able to over-produce proline, making the host E. 
coli strain more resistant to osmotic stress [69].  While this work does not support 
channeling directly, it does show that enhancing the proximity of two active sites can 
significantly increase the efficiency of a metabolic pathway [69].   
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Structural data supporting channeling is not directly available for GK and GPR 
enzymes [70]. Figure 8 shows the individual structures of E. coli GK (EcGK) and T. 
maritima GPR (TtGPR). Marco-Marin et al modeled a possible interaction between 
monofunctional GK and GPR, showing GPR in both an open and closed conformation, 
depending on the binding status of the substrate [32].  The model shows a tetrameric form  
 
 
Figure 8- Structures of GPR from T. maritima (TmGPR) and GK from E. coli 
(EcGK).  EcGK is shown as a dimer with one monomer shown in surface representation 
and the other monomer as a ribbon cartoon illustration. Glutamate is shown as spheres in 
the substrate binding pocket, which is solvent accessible. Only one monomer of GPR 
(open conformation) is shown, which contains three domains:  NADPH binding domain 
(yellow), catalytic domain (blue) with the catalytic cysteine shown in spheres, and the 
oligomerization domain (black). The solvent-exposed glutamate binding pocket of GK 
suggests that the γ-glutamyl phosphate intermediate would be accessible to GPR in a 
potential GK-GPR complex.  A GK-GPR complex in which the catalytic domain of GPR 
is aligned with the glutamate binding pocket of GK has been proposed and modeled by 
Marco-Marin et al [32]. Models shown here were made using PyMol [57] and PDB IDs: 
2J5T (EcGK) and 1O20 (TmGPR). 
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of GK from E. coli complexed with a dimer of GPR from T. maritime [32].  In solving 
the crystal structure EcGK, Marco-Marin et al. noted that GK was well suited for 
channeling [32].  They suggested that channeling is possible if the GK and GPR active 
sites are positioned so that the active site cysteine of GPR is able to react with γ-glutamyl 
phosphate while still bound at the GK active site.  A complex as described would allow 
for a favorable environment and timely transfer of γ-glutamyl-phosphate to the second 
active site thereby preventing cyclization to 5-oxoproline [32].  Additionally it has been 
suggested that leucine zipper motifs found in the GK and GPR domains of plants, as well 
as the GK and GPR enzymes of some bacteria are evidence for a functional complex 
[71].  The leucine zipper of plant P5CS may help with oligomerization or it may be an 
artifact of evolution.  Several domain swapping experiments have shown that leucine 
zippers mediate protein-protein dimerization in eukaryotic and prokaryotic enzymes. 
Thus, the leucine zippers in bacterial GK and GPR enzymes and plant P5CS may support 
a possible channeling complex [72].   
SUMMARY 
 Proline metabolism has become a very important area of study due to its 
involvement in many different cellular processes from maintaining redox balance to 
countering environmental stress. As described in this review, substrate channeling is a 
relevant mechanism in proline metabolism for translocating important intermediates 
between active sites.  Rational for substrate channeling in proline metabolism is two-fold. 
First, the equilibrium for the hydrolysis of P5C to GSA is unfavorable at physiological 
pH indicating channeling may be necessary to increase the overall conversion efficiency 
of proline into glutamate. Second, P5C/GSA and γ-glutamyl-phosphate are reactive and 
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labile intermediates. Channeling of these intermediates would protect against the 
formation of unwanted products, such as 5-oxoproline from γ-glutamyl-phosphate. 
Future kinetic and structural studies are important for understanding the 
mechanisms of substrate channeling in proline metabolism.  In proline catabolism, 
BjPutA provides structural and kinetic data supporting channeling, but more work needs 
to be done on trifunctional and monofunctional enzymes. Substrate channeling in PutAs 
suggests that bacteria have evolved a strategy to limit the availability of P5C to other 
competing pathways. P5C is at the crossroads of important metabolic pathways, which 
include proline oxidation, urea cycle, TCA cycle via glutamate, and the proline 
biosynthetic pathway [73]. Substrate channeling by PutA may help maintain flux through 
the proline oxidative pathway, which would be especially important under poor nutrient 
conditions in cells starved for nitrogen and glutamate and other downstream products 
such as α–ketoglutarate. Whether P5C/GSA is channeled in Gram-positive bacteria and 
eukaryotes is not yet known. Studies of PRODH-P5CDH coupled kinetics and potential 
PRODH-P5CDH interactions are needed to address channeling between monofunctional 
PRODH and P5CDH enzymes. In proline biosynthesis, evidence for interactions between 
monofunctional GPR and GK has been reported, but structural evidence for channeling in 
bifunctional P5CS is currently not available. Although channeling interactions between 
GK and GPR seem likely and are supported by several studies, additional work is 
required to define the channeling pathway and mechanisms in proline biosynthesis. To 
date, a full-length structure of P5CS has not been reported. Solving a crystal structure of 
P5CS would be a significant step toward understanding channeling of γ-glutamyl 
phosphate.  Not only would a complete structure of P5CS act as a template for modeling 
24 
 
 
 
the interaction between monofunctional GK and GPR, but it could also be used to 
identify cavities within the protein that may act as channels for transporting γ-glutamyl 
phosphate between active sites.  
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CHAPTER 2 
 
Investigation of substrate 
channeling between 
monofunctional PRODH and P5CDH 
enzymes of Thermus thermophilus 
 
Note: The results discussed in this chapter are being prepared for manuscript 
“Evidence for substrate channeling in monofunctional proline metabolic enzymes of 
Thermus thermophilus.” Sanyal N, Tanner JJ, Becker DF. Manuscript in preparation.   
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INTRODUCTION 
The oxidative conversion of proline to glutamate involves two enzymes, a flavin 
dependent proline dehydrogenase (PRODH) and a NAD
+
-dependent ∆1-pyrroline-5-
carboxylate (P5C) dehydrogenase (P5CDH). PRODH and P5CDH help organisms 
respond to changes in the nutritional environment by initiating the breakdown of proline 
as a source for nitrogen, carbon, and energy [1-6] (Scheme 1). In Gram negative bacteria 
such Escherichia coli and Bradyrhizobium japonicum, PRODH and P5CDH catalytic 
domains are fused into one polypeptide known as proline utilization A or PutA [7]. 
P5C and γ-glutamate semialdehyde (GSA) are the intermediates of the proline and 
ornithine metabolic pathways [8]. The interconversion of P5C and GSA occurs via a non-
enzymatic pH-dependent hydrolysis.  P5C/GSA are appreciably labile and have been 
shown to react with metabolites, inhibit enzymes, and act as signaling molecules. GSA 
has been reported to inhibit glucosamine-6-phosphate synthase from E. coli, cytidine 5’-
triphosphate synthase, and the amidotransferase domain of carbamoyl phosphate 
synthetase [9-11].   
 
 
Scheme 1- An overview of the two-step oxidation of proline by proline dehydrogenase 
(PRODH) and ∆1-pyrroline-5-carboxylate dehydrogenase (P5CDH). The physiological 
electron acceptor for PRODH during catalytic turnover is assumed to be a membrane 
bound electron carrier such as ubiquinone. Figure is adapted from [15].  
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Additionally, P5C forms adducts with other metabolites such as pyruvic acid, 
oxaloacetic acid, and acetoacetic acid [12].  P5C can also react with pyridoxal phosphate 
in patients with type II hyperprolinemia. The high levels of P5C/GSA generates inactive 
adducts with pyridoxal phosphate, leading to lower amounts of functional vitamin B6 in 
patients [12].  P5C also acts as a signaling molecule in eukaryotes and is thought to 
induce apoptosis by increasing intracellular reactive oxygen species [13, 14].   
Altogether, it seems that controlling the levels of free P5C/GSA would be 
beneficial for the cell. The instability of the intermediates and competition from proline 
biosynthetic and ornithine metabolic pathways implies substrate channeling may be 
important for maintaining efficient proline catabolic flux. Substrate channeling is a 
phenomenon where the product of one reaction is transported to a second active site 
without equilibrating into bulk solvent [16].  
Our previous study using enzyme kinetic measurements and X-ray 
crystallography in collaboration with Dr. John Tanner’s laboratory (University of 
Missouri-Columbia) has shown that the PRODH and P5CDH domains of bifunctional 
PutA (BjPutA) from Gram-negative Bradyrhizobium japonicum are connected by a large, 
elongated channel [15]. Kinetic data have shown that substrate channeling in BjPutA 
facilitates product formation by decreasing the transient time for glutamate production. 
Using small-angle X-ray scattering (SAXS), similar occurrence of substrate channeling 
has also been proposed in PutA from Escherichia coli [17]. Thus, a general feature of 
PutA’s may be the sequestering of the P5C/GSA intermediate and efficient transfer of 
P5C/GSA from PRODH to the P5CDH active site without equilibrating with the contents 
of the cytoplasm.  
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The 4e- oxidation of proline to glutamate by PRODH and P5CDH enzymes is 
highly conserved in all domains of life [7]. However, unlike Gram-negative bacteria, 
organisms such as Gram-positive bacteria and eukaryotes express separate 
monofunctional PRODH and P5CDH enzymes (Figure 1). Table 1 shows that 
intracellular proline concentrations are within an order of magnitude in various 
representative organisms.  
 It is thus anticipated that the oxidation of proline by PRODH would lead to 
significant amounts of P5C/GSA formation and, as mentioned above lead to deleterious 
effects such as inhibition of nucleoside synthesis, PLP-dependent enzymes and other 
metabolic processes impacted by P5C/GSA. To prevent substantial build-up of P5C/GSA 
in these organisms, the expression and activity levels of PRODH and P5CDH would need 
to be highly coordinated. As part of the mechanism by which organisms regulate proline 
metabolic flux, it is feasible that PRODH and P5CDH form a bienzyme complex. To 
date, however, no studies have been performed to test substrate channeling and potential 
interactions between monofunctional PRODH and P5CDH enzymes. It is not known 
whether monofunctional PRODH and P5CDH enzymes physically interact to form an 
internal cavity and to facilitate P5C/GSA channeling similar to bifunctional PutAs.  
The main objective of this study is to investigate substrate channeling between 
monofunctional PRODH and P5CDH from Thermus thermophilus. PRODH from 
Thermus thermophilus (TtPRODH) was previously characterized and shown to be a 35 
kDa flavoprotein containing a triosephosphate isomerase (TIM) barrel (β8α8) catalytic 
domain [18, 19]. TtPRODH shares the catalytic β8α8 fold domain previously reported for 
bifunctional PutA (White, Krishnan et al. 2007). P5CDH from Thermus thermophilus  
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Figure 1- Phylogenetic tree representation of proline oxidative enzymes. Branch 1 
and Branch 2 organisms, most of which are Gram-negative bacteria, encode for the 
bifunctional enzyme, PutA. Branch 3B displays organisms from Archaea and bacteria 
that express monofunctional PRODH and P5CDH. Examples of such organisms include 
Thermus thermophilus, Deinococcus radiodurans, and Staphylococcus aureus.  Branch 
3A includes all eukaryotic organisms. Figure from [7] with permission from source. 
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Table 1- Intracellular proline concentrations in various organisms under non-
stressed conditions. 
 
 
 
(TtP5CDH) has also been previously characterized and is a 57kDa protein that exists as 
hexamer in crystal form [18, 19]. Because TtPRODH and TtP5CDH are the best 
characterized pair of monofunctional enzymes in proline metabolism, they were chosen 
for studying substrate channeling in vitro.  
The main strategy for testing substrate channeling is adapted from the work of 
Geck and Kirsch [20] and is illustrated in Figure 2. Using proline as a substrate, the 
amount of NADH generated, which is equivalent to the amount of glutamate product, is 
measured in assays using an equimolar mixture of TtPRODH andTtP5CDH. This coupled 
assay is called a channeling assay. The experiment is carried out in the presence of 
increasing amounts of catalytically inactive mutants of TtP5CDH or TtPRODH. In these 
assays, evidence for channeling between TtPRODH and TtP5CDH is considered when 
NADH formation decreases with increased amounts of the inactive mutant. For example, 
if PRODH and P5CDH form a channeling complex, the addition of an excess amount of a 
Organism Intracellular Proline Source
Escherichia coli
27.8 mM (Chen, Cao et al. 2006) [51]
0.39 mM (Bennett, Kimball et al. 2009) [52]
Salmonella typhimurium 0.11 mM (Csonka 1988) [53]
Bacillus subtilis 16.4 mM
(Whatmore, Chudek et al. 1990; 
Roesser and Muller 2001) [54, 55]
Thermus thermophilus 8.78 mM (Kosuge and Hoshino 1998) [56]
Saccharomyces cerevisiae
3.15 mM (Chen, Wanduragala et al. 2006) [57]
2.9 mM (Morita, Nakamori et al. 2003) [58]
Human plasma 0.1 – 0.26 mM (Jaksic, Wagner et al. 1990) [59]
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P5CDH inactive mutant would compete with native P5CDH for binding to TtPRODH. 
This would result in formation of a complex where the second enzyme is inactive and, 
thus, the rate of the coupled proline to glutamate conversion would decrease (Figure 2).  
Conversely, inactive mutants of TtPRODH could also interfere with a 
TtPRODH/TtP5CDH channeling complex and yield similar results. If substrate 
channeling does not occur, the presence of the inactive mutant should not affect the rate 
of NADH formation.  
 
 
Figure 2- Strategy for testing substrate channeling between monofunctional 
PRODH and P5CDH. E1 and E2 represent PRODH and P5CDH respectively. A, B and 
C represent proline, P5C/GSA and glutamate, respectively. 
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The strategy outlined in Figure 2 has been used previously to demonstrate 
substrate channeling between muscle aldolase and fructose 1,6-bisphosphatase [21] and 
between aspartokinase and aspartate semialdehyde dehydrogenase [22]. More frequently, 
however, the above strategy has been used to rule out substrate channeling such as 
between aspartate aminotransferase and malate dehydrogenase [20] and for methyl 
erythritol phosphate biosynthetic enzymes IspDF and IspE  [23].  
Channeling of an intermediate requires some form of interaction between the pair 
of enzymes, regardless of how transient or stable the interactions might be. Without 
sufficient interactions between enzyme pairs, the intermediate is likely to quickly diffuse 
into the bulk solvent. Hence, to support the kinetic studies on substrate channeling, 
protein-protein interactions between TtPRODH and TtP5CDH were also investigated 
using surface plasmon resonance (SPR). SPR is a sensitive and powerful tool for 
detecting and measuring biomolecular interactions [24]. Properly designed SPR 
experiments not only provide estimates of protein-protein binding affinities but also the 
kinetic parameters of the binding event.  
Substrate channeling has been demonstrated for PutA and other multifunctional 
enzymes [25-27] and, individual enzymes proximally docked onto a scaffold [28, 29]. 
The scientific novelty of this study is the evidence for substrate channeling between two 
separate enzymes.  
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EXPERIMENTAL PROCEDURES 
Materials 
All chemicals and buffers were obtained from Sigma-Aldrich or Fisher Scientific 
unless otherwise noted. DL-P5C was chemically synthesized from DL-hydroxylysine as 
described previously by Williams and Frank and stored in 1M HCl at 4
o
C. [30]. D,L-P5C 
contains equimolar concentration of D-P5C and L-P5C. N-(Biotinoyl)-N'-
(iodoacetyl)ethylenediamine (BIAM) and dimethyl sulfoxide (DMSO) were obtained 
from Molecular Probes. The streptavidin (SA) sensor chip and PD-10 desalting columns 
were purchased from GE Healthcare. The molecular interaction between TtPRODH and 
TtP5CDH was studied using a BIAcore 3000 (BIACORE AB, Uppsala, Sweden) 
instrument maintained in the Molecular Interaction Core Facility at the University of 
Nebraska Medical Center. Assays for enzymatic activities of PRODH and P5CDH were 
carried out on a Cary-50 UV-Vis spectrophotometer (Varian) or Powerwave XS 
Microplate reader (BioTek). Substrate channeling assays were carried out on a SF-
61DX2 stopped-flow spectrophotometer (TgK Scientific, UK). The TtP5CDH-pKA8H 
construct and purified DrP5CDH inactive mutant (C325A) were generous gifts from Dr. 
John Tanner at the University of Missouri-Columbia. 
Constructs and site-directed mutagenesis  
The TtPRODH and TtP5CDH genes were expressed from a pKA8H expression 
vector as previously described [18, 19]. The PUT2 gene encoding P5CDH from 
Saccharomyces cerevisiae (Put2p) was cloned into a pET14b expression vector (pET14b-
PUT2) as described in Chapter 3 of this thesis. Site-directed mutagenesis for active site 
and surface mutations was performed using the GeneTailor mutagenesis kit (Invitrogen). 
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The mutants generated in this study and the corresponding primers used for introducing 
active site mutations are listed in Table 2.  The codon change for mutagenesis is 
highlighted in bold letters. All mutations were confirmed by DNA sequencing. 
 
Table 2 – List of primers used for site-directed mutagenesis 
  
Purification of TtPRODH and TtP5CDH enzymes 
All proteins were expressed and purified from E. coli strain BL21(DE3) pLysS 
with a N-terminal 6xHis tag using the pKA8H construct as described here. pKA8H 
constructs for expressing wild-type TtPRODH, TtPRODH R288M/R289M, TtPRODH 
S8C, TtPRODH A88C, wild-type TtP5CDH, and TtP5CDH C322A, and pET14b-PUT2 
were transformed separately into E. coli BL21(DE3) pLysS. For enzyme expression and 
purification, newly transformed cells were plated onto Luria-Bertani (LB) agar 
Mutation Primer Sequence
TtP5CDH C322A
Forward primer 5’ acggcttccaggggcagaaggcctccgcggcga 3’
Reverse primer 5’ cttctgcccctggaagccgtaggcggagac 3’
TtPRODH 
R288M/R289M
Forward primer 5’ actggtacccctacctcaccatgatgatcgcggagag 3’
Reverse Primer 5’ ggtgaggtaggggtaccagtcccggccgtag 3’
TtPRODH S8C
Forward primer 5’ cctggacctggcttaccgttgcttcgtgctcgg 3’
Reverse primer 5’ aacggtaagccaggtccaggttcat 3’
TtPRODH A88C
Forward primer 5’ ttgagctcgtctgggccctttgcgggaagccct 3’
Reverse Primer 5’ a agggcccagacgagctcaaggagccccct 3’
Put2 C351A
Forward primer 5’ tcgagttccaaggccaaaaggcctctgccgctt 3’
Reverse Primer 5’ agaggcactttcgagttccaaggccaaaag 3’
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containing chloramphenicol (34 µg/ml) and ampicillin (50 µg/ml). Resulting colonies 
were inoculated in 5 ml of LB broth containing the necessary antibiotics and grown to an 
optical density at 600 nm (OD600) of 1.0. 1 ml of the LB culture was then used to 
inoculate 1 L of LB Broth media containing chloramphenicol (34 µg/ml) and ampicillin 
(50 µg/ml).  The 1 L cultures were incubated at 37
o
C with shaking (250 rpm) until OD600 
of 0.8 at which point protein expression was induced with 0.5 mM IPTG overnight at 
20
o
C.  
The overnight cultures were centrifuged at 6000 rpm for 20 min at 4
o
C. The 
resulting pellets were resuspended in a final 50 ml volume of binding buffer (20 mM 
Tris, 5 mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) supplemented with protease 
inhibitors (3 mM -amino-N-caproic acid, 0.3 mM phenyl methyl sulfonyl chloride, 1.2 
µM leupeptin, 48 µM N-p-tosyl-L-phenyl alanine chloromethyl ketone, 78 µM N- p -
tosyl-L-lysine chloromethylketone). 1 mM FAD and 0.25% Triton-X 100 was 
additionally supplemented for purification of wild-type TtPRODH and TtPRODH mutant 
R288M/R289M. Cell suspensions were disrupted by sonication at 4
o
C for a total of 5 min 
(5 sec pulse on, 15 sec pulse off, 40% power). The cell extract was centrifuged at 16000 
rpm (4
o
C) for 60 min. The supernatant (50 ml) was passed through a 0.8 µm filter (VWR) 
and applied to a Ni-NTA superflow (Qiagen) resin (25 ml bed volume in a 2.8 cm x 30 
cm column) equilibrated with 1X binding buffer. Wash buffer (125 ml, 20 mM Tris, 60 
mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) was then applied to the column 
followed by elution buffer (20 mM Tris, 500 mM imidazole, 0.5 M NaCl, 10% glycerol, 
pH 7.9) with a flow rate of 3 ml/min to elute His-tagged recombinant proteins. Fractions 
from the elution step were then analyzed by SDS-PAGE and pooled. Pooled protein was 
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then dialyzed into 50 mM Tris buffer (pH 8.0) containing 25 mM NaCl, 10% glycerol, 
0.5 mM Tris (3-hydroxypropyl) phosphine (THP) and concentrated using an Amicon 30-
kDa cutoff filter (Millipore). The final concentration of purified protein was determined 
using the BCA method and is expressed as concentration of monomer unless stated 
otherwise [23]. The 6xHis tag was not removed after purification. 
Measurement of PRODH and P5CDH activities 
PRODH Activity 
TtPRODH activity was measured at 25
o
C using Coenzyme Q1 (CoQ1) as the 
terminal electron acceptor. For measurement of kinetic parameters for proline and CoQ1, 
TtPRODH (0.5 μM) was mixed in 50 mM phosphate buffer at pH 8.0 with varying 
proline (0-100 mM) and fixed CoQ1 concentrations (150 µM) or varying CoQ1 (0-300 
M) and fixed proline concentrations (150 mM). Reaction progress was monitored by 
following reduction of CoQ1 at 275 nm (ε= 13700 cm
-1
 M
-1
) using a 0.15 cm path length 
on a Hi-Tech Scientific SF-61DX2 stopped-flow instrument at 25
o
C [31].  The kinetic 
parameters Km and kcat were estimated by regression analysis of the initial reaction 
velocity versus proline concentration using the Michaelis-Menten equation and 
Lineweaver-Burk plot analysis [32].  Proline:dichlorophenolindophenol (DCPIP) 
oxidoreductase assay was used for measurement of specific activity of TtPRODH in a 1-
ml reaction volume using Cary 100 and Cary 50 UV-visible spectrophotometers [33].  
The DCPIP assay mixture contained 0.2 μM of TtPRODH enzyme, 0.27 mM phenazine 
methosulfate, 75 μM DCPIP and 300 mM proline in 20 mM Tris at pH 8.0. The rate of 
DCPIP reduction was measured at 595 nm (ε = 16100 cm-1 M-1) [33]. One unit of 
PRODH is defined as the amount of enzyme that reduces 1 µmole of DCPIP per min. 
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Test for the effect of TtP5CDH C322A and BSA on TtPRODH activity was done using 
the proline:DCPIP oxidoreductase assay with 1 mM proline as substrate and 1 to 25 µM 
concentrations of TtP5CDH C322A and BSA. 
P5CDH Activity 
P5CDH activity was measured by monitoring the formation of NADH at 340 nm 
(ε = 6400 cm-1 M-1) at 25 °C. The assay buffer contained 50 mM potassium phosphate 
(pH 7.5) and 25 mM NaCl. P5CDH enzyme concentration was 0.5 µM (30 g/ml) and 
NAD
+
 concentration was 0.2 mM. Varying concentrations of L-P5C ranging from 1 to 
300 µM were used.  Initial rates were fitted to a Michaelis-Menten equation (equation 
2.1).    
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Inhibition studies of P5CDH activity were carried out using the assays conditions 
described above with increasing concentrations of proline (0-15 mM). Initial velocities  
as function of P5C concentration at different proline concentrations were fitted to a 
competitive inhibition model (equation 2.2) using SigmaPlot 12 Enzyme Kinetics 
Module (Systat Inc.), where v is P5CDH velocity (µM/sec), [E]T is P5CDH concentration 
(µM), kcat (sec
-1
) and Km (µM) are the Michaelis-Menten constants for P5CDH, [S] is L-
P5C concentration (µM), [I] is the proline concentration (µM) and KI is the competitive 
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The effect of TtPRODH R288M/R289M on TtP5CDH was carried out similarly to the 
assays described above using 100 µM L-P5C as a substrate and varying TtPRODH 
R288M/R289M from 1 to 25 µM in the assays.  
Test for substrate channeling 
Optimization of the TtPRODH:TtP5CDH ratio for channeling assays 
Varying concentrations of TtPRODH (0.1 µM to 10 µM) were mixed with 0.5 
µM of TtP5CDH in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl.  A separate 
substrate solution was prepared by mixing proline (1 mM), CoQ1 (0.1 mM), and NAD
+
 
(0.2 mM) in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. Equal volumes of 
the substrate and enzyme solutions were then mixed via single-mixing on a SF-61DX2 
stopped-flow spectrophotometer. The reaction was monitored at 340 nm with a 1 cm path 
length observation cell. A molar extinction coefficient of 6400 cm
-1
 M
-1
 [34] was used to 
calculate concentration of NADH formed during the coupled assay. 
The strategy described by Geck and Kirsch [20] was used for testing substrate 
channeling between TtPRODH and TtP5CDH. The experiment uses proline as the 
substrate for PRODH and monitors formation of NADH, a product of P5CDH activity. 
This coupled reaction (channeling assay) is performed at increasing concentrations of 
inactive mutants of TtP5CDH and TtPRODH. The inactive mutants of P5CDH were 
TtP5CDH C322A, DrP5CDH C325A, and Put2p C351A. The inactive mutant of 
TtPRODH used for these assays was TtPRODH R288M/R289M. The lack of enzymatic 
activity in the TtPRODH and TtP5CDH mutants was confirmed by activity assays 
described above. Bovine serum albumin (BSA), a protein unrelated to proline 
metabolism, was used as negative control in the channeling assays. The final 
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concentration of TtPRODH and TtP5CDH used in these assays was 0.5 µM of monomer 
each. The final concentrations of catalytically inactive mutants were 0, 1, 2, 3, 5, 12.5, 
and 25 µM (monomer). This resulted in 0 – 50 fold inactive mutant to wild-type enzyme 
ratio.  
 For the channeling assays, a mixture of TtPRODH (0.5 µM) and TtP5CDH (0.5 
µM) was prepared in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. A separate 
substrate solution was prepared by mixing proline (1 mM), CoQ1 (0.1 mM), and NAD
+
 
(0.2 mM) in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. Equal volumes of 
the substrate and enzyme solutions were then mixed via single-mixing on a SF-61DX2 
stopped-flow spectrophotometer. The reaction was monitored at 340 nm with 1 cm path 
length observation cell. Molar extinction coefficient of 6400 cm
-1
 M
-1
 [34] was used to 
calculate the concentration of NADH formed during the channeling assay.  Reduction of 
CoQ1 alone causes a minor spectral decrease at 340 nm due to the absorbance overlap of 
CoQ1 at 340 nm. To correct for this interference, the absorbance decrease at 340 nm due 
to CoQ1 reduction was subtracted from the channeling assays by recording changes at 
340 nm in the absence of NAD
+
. Linear regression analysis was used for determining the 
rate of NADH formation in each assay. The change in NADH formation rates are also 
presented as the percent channeling activity relative to assays without inactive mutant.  
The non-channeling PRODH-P5CDH reaction was simulated as previously 
described [35] using a diffusion-limited two-enzyme model (Equation 2.3, 2.4). 
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In the above equation, v1 is the experimentally determined rate of PRODH activity under 
the specified assay conditions with 1 mM proline, t is time in sec, Km2 (42.5 µM L-P5C) 
and v2 (0.26 µM/sec) are the steady-state Michaelis-Menten constants Km and V, 
respectively, for TtP5CDH, and τ is the transient time (sec) required to attain steady-state 
formation of product (i.e., NADH).  
Biotin labeling of TtPRODH  
TtPRODH mutants S8C and A88C were purified as described above and labeled 
with biotin at the newly incorporated cysteine residue using the thiol-reactive N-
(Biotinoyl)-N'-(iodoacetyl)ethylenediamine (BIAM) reagent. A 5 mM stock of BIAM 
was prepared by dissolving in DMSO. Under anaerobic conditions, purified TtPRODH 
mutants S8C and A88C and BIAM were mixed at final concentrations of 51 µM 
(TtPRODH) and 715 µM (BIAM). After allowing the labeling reaction to proceed 
overnight at 4
o
C, 25 mM β-mercaptoethanol was added to quench the unreacted BIAM. 
Crude biotin-labeled TtPRODH was separated from the quenched BIAM using a PD-10 
desalting column. The concentration of total protein was measured using the Pierce 660 
nm Protein Assay Reagent (Pierce). Biotin labeling of TtPRODH was confirmed by 
Western blot analysis using streptavidin-conjugated Horse Radish Peroxidase (Pierce). 
ECLprime reagents (GE Healthcare) were used for detection and visualization of biotin-
labeled TtPRODH. 
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Protein-protein interaction analysis by SPR 
Immobilization of TtPRODH on streptavidin sensor chip 
The streptavidin (SA) sensor chip was first washed with HBS-EP buffer (10 mM 
HEPES, pH 7.4, 0.15 M NaCl, 3.4 mM EDTA, and 0.05% surfactant P20) for 6 min (20 
µl/min flow rate). Prior to immobilization, the SA sensor chip was activated with three 
consecutive 40 µl injections of activating buffer (1 M NaCl and 50 mM NaOH). 
Biotinylated TtPRODH mutants S8C and A88C were then diluted in HBS-EP to a final 
concentration of 250 µM and injected with a flow rate of 5 µl/min onto flow cells 2 
(TtPRODH S8C) and 4 (TtPRODH A88C). Sensor chip flow cells 1 and 3 were not 
exposed to TtPRODH mutants and were used as reference cells.  
Preliminary experiments were carried out to test the interaction of immobilized 
TtPRODH S8C and A88C ligands with analytes such as TtP5CDH, DrP5CDH and BSA. 
The analytes were equilibrated in HBS-EP buffer and diluted to a concentration of 1 µM 
immediately prior to injection. Each protein analyte was then injected onto flow cells 1-4 
for 2 min followed by a 5 min dissociation phase at a flow rate of 30 µl/min.  
Binding analysis of TtP5CDH 
The SA sensor chip with immobilized TtPRODH A88C on flow cell 4 was first 
washed with regeneration buffer (2 M NaCl) at a flow rate of 30 µl/min for 3 min 
followed by equilibration with HBS-EP buffer (30 µl/min). Wild-type TtP5CDH was 
equilibrated with HBS-EP buffer and diluted to different concentrations ranging from 0.5 
to 7.5 µM (monomer). From lowest to highest concentration, wild-type TtP5CDH was 
injected for 2 min (30 µl/min) followed by a 5 min dissociation phase at a flow rate of 30 
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µl/min with HBS-EP buffer. The SA sensor chip was regenerated using 90 µl of 2 M 
NaCl (30 µl/min) and equilibrated with HBS-EP buffer (30 µl/min, 5 min) after each 
injection of TtP5CDH.  The resulting sensorgrams were globally fitted to 1:1 Langmuir 
PRODH-P5CDH binding model using BIA-evaluation software 3.1. The experiments 
were carried out at 25
o
C. All buffers were filtered and degassed prior to injection on SA 
sensor chip.  Signals from the reference flow cells were subtracted from the sensorgrams. 
RESULTS 
Competitive inhibition of TtP5CDH by proline 
The crystal structure of TtP5CDH [19] shows several ligands containing a 
carboxylate moiety (COO
-
) bind at the TtP5CDH active site. L-proline (PDB ID:2J40) 
and glutamate (PDB ID:2BHQ) were among these ligands. The carboxyl moiety of 
proline is 2.7 Å from the hydroxyl group of active site Ser321 and 3.0 Å from the 
backbone amide nitrogen atoms of Gly477 and Ala478 (Figure 3A). Such bond distances 
can favor hydrogen bonding or electrostatic interaction and thereby stabilize ligand 
binding [36]. The orientation of the carboxyl group of the other ligands is identical to 
proline and glutamate. This suggests that the binding of proline to the active site is stable 
and not an artifact of TtP5CDH crystallization. Hence, we decided to test the possibility 
of proline as an inhibitor of TtP5CDH.  
The effect of proline on P5CDH initial velocity was determined and is shown as a 
direct plot in Figure 3B and a double reciprocal plot of 1/v versus 1/[S] with varying 
proline concentrations in Figure 3C. The steady-state kinetic parameters for TtP5CDH 
were estimated as Km of 42.7 µM DL-P5C and kcat of 0.52 s
-1
 (Table 3). As is 
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Figure 3- Competitive inhibition of TtP5CDH by L-Proline.  A) Molecular 
representation of L-proline bound to TtP5CDH active site (PDB ID:2J40). Ligands L-
proline and NAD
+
 are represented as sticks. Distance between carboxyl moiety of proline 
and active site residues are shown using yellow dotted line with distance represented in 
Å. TtP5CDH is represented as cartoon (cyan). Figure was generated using PyMol 
molecular graphics system [37]. B) Michaelis-Menten plot and C) Double reciprocal plot 
of initial velocity TtP5CDH versus L-P5C substrate concentration with proline as 
competitive inhibitor with concentrations 0 mM (●); 2 mM (○); 4 mM (▼); 6 mM () ; 
8 mM (); 10 mM (); and 15 mM (). Regression analysis was performed by global 
fitting of data to Michaelis-Menten equation using Sigmaplot 12 (Systat Software Inc.). 
Kinetic parameters from the fitting are kcat = 0.43 ± 0.02 sec
-1
, Km = 27.7 ± 4.3 µM, and 
KI(pro) = 3.9 ± 0.7 mM proline. 
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characteristic of competitive inhibition, the apparent V of P5CDH does not change with 
inhibitor (proline) concentration. The data fits well with a competitive inhibition model 
(equation 2.2) with an inhibition constant (KI) of 3.9 mM proline. In order to eliminate 
interference from proline acting as a competitive inhibitor of P5CDH, we chose to test 
TtPRODH-TtP5CDH substrate channeling using proline concentrations < 3.9 mM. The 
subsequent channeling assays were thus performed with 1 mM proline, which is not only 
< KI(pro), but is also below Km(pro) for TtPRODH. The kinetics parameters determined for 
TtPRODH are Km of 8.19 ± 0.34 mM proline and 162.2 ± 7.6 µM CoQ1 with overall kcat 
of 17.04 ± 0.42 sec
-1
.  
TtPRODH-TtP5CDH coupled reaction and non-channeling two-enzyme modeling 
 
Figure 4 – Effect of TtPRODH enzyme concentration on channeling reaction. NAD+ 
reduction rate was calculated from slope of progress curves at 340 nm. The reaction 
mixture contained 0.5 µM TtP5CDH, 1 mM proline, 0.2 mM NAD+, and 0.1 mM CoQ1. 
TtPRODH was varied from 0.1 µM to 10 µM. Assays for each TtPRODH concentration 
was carried out in triplicate. 
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Before performing TtPRODH-TtP5CDH channeling assays, the ratio of 
TtPRODH:TtP5CDH was first optimized. This was done to ensure that the coupled 
TtPRODH-TtP5CDH reaction was not limited by the concentration of either enzyme. 
Figure 4 shows the dependence of NADH formation on the concentration of TtPRODH. 
Keeping TtP5CDH fixed at 0.5 µM, NADH formation plateaus above 1 µM TtPRODH. 
Thus, an equimolar mixture of 0.5 µM TtPRODH and 0.5 µM TtP5CDH was considered 
to be appropriate for testing substrate channeling.  
The rate of NADH formation using an equimolar mixture of TtPRODH-TtP5CDH 
(0.5 µM:0.5 µM) was compared to that of a diffusion-limited two-enzyme reaction model 
(equation 2.3). Figure 5 shows that an equimolar mixture of TtPRODH-TtP5CDH 
exhibits a velocity of 0.0803 µM NADH/sec. Simulating a non-channeling reaction for 
the formation of NADH by TtPRODH and TtP5CDH using equation 2.3 generates a rate 
of 0.0804 µM/sec. The simulated steady-state rate of NADH formation is identical to the 
experimental rate, however, the transient time for TtPRODH-TtP5CDH to attain steady-
state formation of NADH is much longer for the simulated non-channeling reaction than 
for the experimentally observed reaction.  The predicted transient time for a non-
channeling TtPRODH-TtP5CDH mixture is 164.2 sec, whereas the experimentally 
observed transient time is 38.5 sec. The 4-fold decrease in transient time in the 
experimental curve relative to the simulated curve is suggestive of substrate channeling 
between TtPRODH and TtP5CDH.  The shorter time to reach steady-state formation of 
NADH may be due to increased local concentration of P5C/GSA at the P5CDH active 
site [38].   
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Figure 5- Observed NADH formation from TtPRODH-TtP5CDH channeling assay 
and simulated non-channeling TtPRODH-TtP5CDH reaction. Solid line represents 
NADH formed in a channeling assay by an equimolar mixture of TtPRODH and 
TtP5CDH using 1 mM proline as substrate. Dotted line represents simulated NADH 
formation by a non-channeling two-enzyme model (equation 2.3) using experimentally 
determined values of v1 (0.08 µM/sec), Km2 (42.7 µM), and v2 (0.26 µM/sec).  
 
 
An explanation for decreased lag time to NADH formation could be allosteric 
activation by one of the two enzymes [39]. In a proline:DCPIP oxidoreductase assay with 
1 mM proline, 0.5 µM TtPRODH alone reduces 24.9 µM DCPIP/min whereas addition of 
50-fold excess of inactive TtP5CDH C322A or Put2p C351A changes the rate to 19.26 
and 23.11 µM DCPIP reduced/min, respectively. TtP5CDH was also tested for allosteric 
effects by TtPRODH. With 100 µM L-P5C present as P5CDH substrate, 50-fold excess 
of TtPRODH R288M/R289M caused a slight decrease in TtP5CDH activity from 14.6 
µM NADH formed/min to 11 µM NADH/min. Both TtPRODH and TtP5CDH exhibit a 
negligible inhibitory effect on each other but no evidence of allosteric activation was 
observed. 
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Effect of inactive mutants on TtPRODH-TtP5CDH channeling assays 
To further test the channeling hypothesis, inactive mutants of TtP5CDH and 
TtPRODH were used as competitors of the putative TtPRODH-TtP5CDH channeling 
complex. Inactive TtPRODH (TtPRODH mutant R288M/R289M) was created by 
replacing two catalytic arginine residues (Arg288 and Arg289) which are responsible for 
ionic interactions with the carboxylate moiety of proline thereby stabilizing proline 
binding [40].  The inactive variant of TtP5CDH (TtP5CDH C322A) was generated by 
mutating Cys322 which is the active site nucleophile that attacks the aldehyde carbon of 
GSA and forms an essential thiohemiacetal tetrahedral intermediate. Active site 
mutations did not significantly alter the oligomeric structures of TtPRODH and 
TtP5CDH as observed by size-exclusion chromatography and small-angle X-ray 
scattering (personal communications Dr. John Tanner’s group, University of Missouri-
Columbia).  
Figure 6 shows that the addition of the TtP5CDH inactive mutant (TtP5CDH 
C322A) to a mixture of TtPRODH-TtP5CDH caused a severe decrease in the rate of 
NADH formation (Figure 6A). In the absence of TtP5CDH C322A, the velocity of 
NADH formation by the TtPRODH-TtP5CDH mixture was 0.1 µM NADH/sec whereas 
in the presence of 50-fold excess of TtP5CDH C322A (25 µM) the rate decreased 5-fold 
to 0.02 µM NADH/sec. This is about an 80% decrease in the rate of product formation 
(Figure 6B). The rate of decrease in NADH formation has a linear correlation with the 
amount of TtP5CDH C322A added to the reaction. From an extrapolation on the x-axis, it 
is predicted that 63-fold excess of TtP5CDH C322A would lead to complete inhibition of 
the channeling reaction. The amount of inactive mutant added to the reaction was limited  
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Figure 6- Test for substrate channeling. A) Time course of NADH formation at 340 
nm with varying concentrations of TtP5CDH C322A. The concentration of inactive 
mutant was varied from 0 to 25 µM. Grey bar corresponds to increasing TtP5CDH 
C322A concentration. NADH formation decreases with increasing TtP5CDH C322A 
concentration. The reaction mixture contained 0.5 µM TtP5CDH, 0.5 µM TtPRODH, 1 
mM proline, 0.2 mM NAD
+
, 0.1 mM CoQ1 and increasing concentrations of TtP5CDH 
C322A. Percent channeling rate is calculated from slope of progress curve. B) Percent 
channeling rates are plotted for the different inactive P5CDH and TtPRODH mutants. 
Shown in the plot are- TtP5CDH C322A (), TtPRODH R288M/R289M (●), DrP5CDH 
C325A (), Put2p C351A (○), and BSA (). A linear fit for the effect of each mutant on 
the NADH formation rate is shown.  
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to 50-fold excess due to experimental constraints such as volume of protein added, 
concentration of glycerol and buffering agents required for protein solubility. Addition of 
buffer components alone did not have any effect on the rate of NADH formation. The 
effect of adding the TtPRODH inactive mutant (TtPRODH R288M/R289M) to the 
channeling reaction was similar to TtP5CDH inactive mutant albeit to a lesser extent. At 
a 50-fold excess of TtPRODH R288M/R289M (25 µM) relative to wild-type TtPRODH, 
a 2-fold decrease in the rate of NADH formation was observed from 0.1 µM/sec to 0.054 
µM/sec.   
To test the effects of inactive P5CDH from another organism, inactive mutants of 
P5CDH from D. radiodurans (DrP5CDH C325A) and S. cerevisiae (Put2p C351A) were 
added to the TtPRODH:TtP5CDH reaction mixture. In contrast to inactive TtP5CDH, 
DrP5CDH and Put2p inactive mutants had no significant effect on NADH formation rates 
as shown in Figure 6B. In addition, BSA showed no effect on the TtPRODH:TtP5CDH 
reaction mixture. Interestingly, a slight increase in NADH formation was observed with 
BSA. The slight increase in activity may be attributed to a general stabilizing effect of 
BSA on enzymatic activity [41-44]. Although the mechanism is not fully understood, it 
has been proposed that BSA increases protein stability and decreases interaction of 
enzymes with the reaction vessel and air-solvent interface by acting as a surfactant [42]. 
In summary, the results shown in Figure 6 show that only TtP5CDH C322A and 
TtPRODH R288M/R289M cause a decrease in NADH formation rate. 
Because the highest concentration of inactive mutant in the test for channeling 
assays is 25 µM and, approximately 20 µM P5C is generated during a 200 sec assay, one 
possible explanation for the decrease in NADH formation caused by TtP5CDH C322A is 
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the binding of P5C/GSA by the inactive mutant. Binding of P5C/GSA by an inactive 
P5CDH mutant could possibly decrease the amount of P5C/GSA available for catalysis, 
thereby causing a decrease in the overall formation of NADH. The dissociation constant 
(KD) is the best estimate of substrate binding affinity, however, it is difficult to estimate a 
KD value for  the binding of P5C/GSA to TtP5CDH because P5C/GSA are in a pH-
dependent equilibrium in aqueous solution [9]. For this reason, Km values were used as a 
determinant of substrate binding affinity. Table 3 reports the steady-state kinetic 
parameters that were determined for TtP5CDH, Put2p, and DrP5CDH. The Km value for 
TtP5CDH is 42.7 µM and for Put2p, the Km is 2-fold higher at 104 µM. The Km value for 
DrP5CDH (Km = 282.3 µM) is nearly 7-fold higher than TtP5CDH. If the inactive mutant 
of TtP5CDH decreases channeling simply by binding P5C/GSA, then Put2p would also 
be expected to have an effect on the channeling assay, albeit to a lesser extent (~ 2-fold 
less).  
Table 3 – Steady-state kinetic parameters of monofunctional P5CDH  
from various species 
 
 
The results shown in Figure 6, however, show that Put2p has no effect on NADH 
formation indicating that the effects of the inactive TtP5CDH mutant on the TtPRODH-
TtP5CDH reaction are not caused by sequestration of P5C/GSA. Furthermore, the 
Km (µM L-P5C) kcat (sec
-1) kcat/Km (M
-1sec-1)
TtP5CDH 42.7 1.1 0.52 0.03 1.22x104
DrP5CDH 282.3 6.4 1.6 0.1 5.67x103
Put2p 104.2 4.4 1.49 0.26 1.43x104
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inactive TtPRODH mutant, which does not bind P5C/GSA, also inhibited the TtPRODH-
TtP5CDH reaction consistent with the inactive TtPRODH and TtP5CDH mutants 
lowering NADH formation by disrupting a TtPRODH:TtP5CDH complex. 
Analysis of PRODH-P5CDH interactions by SPR 
In order to further investigate TtPRODH-TtP5CDH substrate channeling, binding 
interactions between TtPRODH and TtP5CDH were investigated by SPR. In the SPR 
analysis, TtPRODH was used as the immobilized ligand and TtP5CDH was the analyte. 
The following strategy was used for biotinylating TtPRODH and immobilizing it on a 
BIAcore streptavidin (SA) sensor chip.  
TtPRODH does not have any cysteine residues. This allowed us to specifically 
introduce cysteine residues on the outer surface of TtPRODH via site-directed 
mutagenesis. After careful analysis of the surface residues, Ser8 located near the N-
terminus and Ala88 located near the top of the PRODH β8α8 barrel were chosen for 
mutagenesis. These residues were strategically chosen for replacing with cysteine so that 
biotinylated TtPRODH could be immobilized on the SA chip in two different 
orientations. Figure 9 shows the predicted orientation of TtPRODH mutants S8C and 
Ala88C after immobilization on the SA chip.  TtPRODH S8C should be immobilized 
near the N-terminus leaving the side and top of the PRODH β8α8 barrel exposed to 
solvent (Figure 9). Conversely, TtPRODH A88C is predicted to be immobilized near the 
top of the PRODH β8α8 barrel with the N-terminus region exposed to solvent. These 
contrasting immobilized configurations allowed us to probe two different regions of 
TtPRODH for binding to TtP5CDH. 
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Purified TtPRODH mutants S8C and A88C required the presence of the reducing 
agent Tris(3-hydroxypropyl)phosphine (THP) to prevent precipitation during purification. 
The specific activities of TtPRODH mutants S8C and A88C were 25.4 U/mg and 19.8 
U/mg, respectively, which are somewhat lower than wild-type TtPRODH (34 U/mg). The 
engineered surface cysteine residues on TtPRODH were biotinylated using the thiol-
reactive BIAM reagent and the incorporation of the biotin label was verified by Western 
analysis as shown in Figure 7. There was some loss of enzymatic activity during the 
labeling procedure. The specific activities for biotin-labeled TtPRODH mutants S8C and 
A88C were 15.4 U/mg and 14.6 U/mg, respectively.    
 
 
Figure 7 – Labeling of TtPRODH with Biotin. TtPRODH S8C and A88C were labeled 
using thiol-reactive biotinylated iodoacetamide (BIAM). Western blotting (bottom panel) 
using streptavidin-HRP confirms biotin labeling of TtPRODH A88C and S8C. PD-10 
desalting column was used for removing excess BIAM.  
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Injection of TtPRODH mutants S8C and A88C elicited a response of 1900 RU 
and 2600 RU, respectively, upon being immobilized on the SA chip. Thus, similar 
amounts of both proteins were immobilized on the SA chip. After washing the 
immobilized surfaces, TtP5CDH (1 µM) was injected onto both surfaces. Figure 8A 
shows that a binding response was observed with immobilized TtPRODH A88C but not 
with immobilized TtPRODH S8C. This result suggests that TtP5CDH distinguishes 
between the two orientations of TtPRODH and specifically recognizes the configuration 
of immobilized TtPRODH A88C.  It also indicates that the immobilized orientation of 
TtPRODH S8C conceals a surface on TtPRODH that is critical for TtP5CDH binding. 
Other analytes were also tested for binding to TtPRODH to rule out non-specific 
interactions. BSA and DrP5CDH did not show any binding response with either 
TtPRODH orientation. This further indicates that the sensorgram response observed with 
immobilized TtPRODH A88C is specific for TtP5CDH.  
We then proceeded to measure the binding kinetics of TtP5CDH with 
immobilized TtPRODH A88C. Increasing concentrations of TtP5CDH were injected onto 
the TtPRODH A88C surface. Figure 8B shows that TtP5CDH binds to TtPRODH A88C 
in a concentration dependent manner.  Global fitting analysis yielded a dissociation 
constant (KD) of 3.03 µM and an association constant (KA) of 3.3 x 10
5
 M
-1
. The 
corresponding kon rate constant for binding was 1.49x10
3
 M
-1
s
-1
 and koff rate constant was 
4.51x10
-3
 s
-1
.  
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Figure 8A– TtP5CDH binds only to TtPRODH immobilized via A88C. SPR 
sensorgram showing binding response after injection of TtP5CDH (1 µM) to immobilized 
TtPRODH S8C and A88C with a flow rate of 30 µl/min (HEPES-EP buffer, pH 7.4). The 
association and dissociation phases were 300 sec each. The sensorgrams show that a 
response is only generated by injection of TtP5CDH onto immobilized TtPRODH A88C. 
Signals from the control flow cells have been subtracted from the sensorgrams. 
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Figure 8B- SPR binding analysis of TtP5CDH and immobilized TtPRODH A88C. 
The concentrations of TtP5CDH injected onto the surface are 0.5 µM (black), 1 µM 
(red), 2 µM (green), 3 µM (yellow), 5 µM (blue), and 7.5 µM (pink). The association 
phase is the injection of TtP5CDH (0.5-7.5 µM) at 30 µl/min for 120 sec and the 
dissociation phase is the flow of HEPES-EP buffer at 30 µl/min for 300 sec.  The 
overlapping black lines are generated from a global fit of the data to a 1:1 Langmuir 
binding isotherm using BIAevaluation 3.0 software. A dissociation constant, KD, of 3.03 
µM was determined for TtPRODH and TtP5CDH interaction. Bottom panel shows the 
plot of the residuals. The chi square value for the fit was 0.579. Signals from the control 
flow cells have been subtracted from the sensorgrams. 
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DISCUSSION 
There is a growing body of evidence that suggests metabolic processes are more 
than just dispersed reactions occurring inside a fluidic container that is, the cell [16, 29, 
45]. There appears to be mechanisms by which several intermediates of metabolism are 
transferred between sequential enzymes while restricting their diffusion in the cytoplasm 
or other cellular compartments [45]. The interactions between enzymes that lead to such 
channeling of intermediates range from strong interactions to weak transient interactions 
with binding affinities (KD) spanning the nM to µM range [46]. In order to identify the 
cellular processes that limit diffusion of metabolites, there is a need to investigate 
substrate channeling at the molecular enzyme level. In the case of proline metabolism, 
Surber and Maloy first observed that PutA from Salmonella typhimurium catalyzed the 
oxidation proline to glutamate by an apparent leaky channel [47]. A more recent study 
from our group in conjunction with Dr. John Tanner’s lab (Missouri, Columbia) 
confirmed this original proposal by reporting structural and kinetic evidence of an 
internal cavity in PutA from B. japonicum for transfer of P5C/GSA from the active site of 
PRODH to P5CDH. 
The experiments discussed in this chapter were designed to explore the possibility 
of substrate channeling in monofunctional PRODH and P5CDH enzymes. Rate 
measurements for the coupled TtPRODH-TtP5CDH enzyme pair demonstrates that 
steady-state formation of NADH is achieved faster than the theoretical approach to 
steady-state by two individual enzymes. Although such rapid product formation can be 
explained by allosteric activation by one enzyme on the other [39], our results show that 
this is not the case for TtPRODH and TtP5CDH. 
62 
 
 
The results from experiments using a catalytically inactive TtP5CDH mutant and 
to a lesser extent the inactive TtPRODH mutant, suggests the presence of a dynamic 
TtPRODH-TtP5CDH interaction. In aqueous buffer, the functional enzyme pair can be 
disrupted by an equally compatible inactive variant of either of TtPRODH or TtP5CDH. 
Being structurally identical to wild-type enzymes, the inactive variants most likely form 
an identical complex as the wild-type enzyme but one which cannot catalyze coupled 
proline oxidation.  
Although suggestive of a binding event between TtPRODH and TtP5CDH, the 
kinetic experiments do not directly provide any information on enzyme interactions. SPR 
was thus used to test for potential physical interactions between TtPRODH and 
TtP5CDH. Unexpectedly, the two orientations of TtPRODH immobilized on the SA chip 
revealed specific binding interactions between TtPRODH and TtP5CDH. In addition, 
DrP5CDH showed no evidence of binding to TtPRODH. Thus, the binding interactions 
observed by SPR between TtP5CDH and immobilized TtPRODH A88C appear to be 
specific. The KD value estimated for the TtPRODH-TtP5CDH complex is ~ 3 µM which 
can be categorized as a weak transient protein-protein interaction [48].  
Based on the evidence presented here and the structural data available for 
TtPRODH and TtP5CDH, a possible model for how TtPRODH and TtP5CDH physically 
interact was explored. Figure 9 shows a representation of the TtPRODH electrostatic 
surface. The structure of the hexameric form of TtP5CDH is shown in Figure 10. The 
hexamer of TtP5CDH has a hollow core along its longitudinal axis of symmetry. This 
hollow cylindrical core, which is approximately 12 Å in diameter and 91 Å in length, 
provides exclusive access to all of the six active sites in the hexamer. Apart from the two  
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Figure 9 –Molecular and surface representation of TtPRODH. A) TtPRODH is 
shown as cartoon representation and colored as rainbow with N-terminus as blue and C-
terminus as red (left.) Side chains of residues Ser 8 (Blue) and Ala 88 (Cyan) are 
displayed as spheres. B) Coulombic surface representation of TtPRODH oriented as 
figure A. C) View turned 180
o
 about the vertical axis. Ser 8 is in a region with basic 
residues whereas Ala 88 is located in a region with acidic side chains. These two residues 
were chosen since they are in two separate regions of TtPRODH with the most noticeable 
surface electrostatics. The coulombic representation used blue color for electropositive 
charge and red color for electronegative charge. Either of these two regions can serve as a 
possible interface with TtP5CDH. Figures were created using monomeric TtPRODH 
structure (PDB ID:2G37) and UCSF Chimera [49].  
 
ends of the hexamer, there are no other major paths into the core. Access to the P5CDH 
active site is not possible from outside the hexmeric core. TtP5CDH shares considerable 
sequence similarity (similarity 51%, Iidentity 37%) and structural homology with the 
P5CDH domain of B. japonicum PutA  If we use the P5CDH active site orientation from 
the BjPutA structure (PDB ID:3HAZ), we will notice that the substrate P5C/GSA must 
enter the core region of TtP5CDH to reach the active site Cys322 and the NAD
+
 cofactor. 
Once GSA is oxidized to glutamate, it appears that glutamate can exit the active site on 
the exterior side of the hexamer. It is possible then, that the inner core of the hexamer 
facilitates capture of P5C/GSA, thus generating a conduit for channeling P5C/GSA.  
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Figure 10 –Molecular and surface representation of TtP5CDH. A) Each chain of 
TtP5CDH hexamer is represented as cartoon and with different color. B) Coulombic 
surface representation of TtP5CDH oriented as left figure A and C) turned 90
o
 about the 
horizontal axis. The Right figure is looking down the inner core of TtP5CDH through 
which all the six active site gain access to substrate glutamate semialdehyde. The 
coulombic representation used blue color for electropositive charge and red color for 
electronegative charge.  Figures were created using hexameric structure of TtP5CDH 
(PDB ID:2J40) and UCSF Chimera [49].  
 
Based on the considerations above, a docking model of TtPRODH and TtP5CDH 
was made using ClusPro [50]. The docking parameters were based on electrostatic 
interactions without any constraints on TtPRODH or TtP5CDH orientation. The model 
predicts favorable docking interactions between the regions of complementary charged 
surfaces of TtPRODH and TtP5CDH. The electropositive N-terminal region of 
TtPRODH (blue surface, Figure 9B) appears to dock in close proximity to an 
electronegative region (red surface, Figure 10C) of TtP5CDH. Interestingly, the proposed 
docking model (Figure 11) is consistent with our results from SPR showing TtP5CDH 
only binds to immobilized TtPRODH A88C. The orientation of TtPRODH A88C would 
allow for the interactions in the docking model whereas the orientation of TtPRODH S8C 
would block the predicted docking interactions.  Further analysis is required to  
90o
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Figure 11- A scheme for substrate channeling overlaid on the predicted docking 
model of TtPRODH-TtP5CDH - TtPRODH and TtP5CDH are shown as transparent 
surfaces with coulombic charge. The orientation of TtP5CDH is identical to that shown in 
Figure 10 B. TtPRODH is shown docked on top of TtP5CDH as predicted by ClusPro 
[50]. NAD
+
 and active residues for each of the six active sites of TtP5CDH are shown as 
colored sticks. The proposed channeling steps are indicated by grey arrows. The  docking 
model suggests that after P5C/GSA exits TtPRODH, P5C/GSA is directed toward the 
inner core of the TtP5CDH hexamer. Hexameric assembly of TtP5CDH could facilitate 
the channeling process by sequestering P5C near the six TtP5CDH active sites. The 
surface representation was created using UCSF Chimera [49]. 
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Glu
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understand the stoichiometry of a putative TtPRODH-TtP5CDH complex considering 
that the TtP5CDH hexamer has a 3-fold symmetry. In addition, a residue conservation 
map of the TtP5CDH surface shows a high degree of variability in residues in the region 
where TtPRODH-TtP5CDH binding is predicted. This could explain why only TtP5CDH 
binds TtPRODH whereas the closely related DrP5CDH does not (sequence similarity 
69%, identity 51%). 
According to a trend observed by Nooren and Thornton, a transient heterodimer 
with a dissociation constant of ~ 3 µM can be expected to have an interface contact area 
of approximately 500 Å
2
 [48]. In order to calculate the interface area between TtPRODH 
and TtP5CDH, a more thorough docking analysis is required that takes into account the 
solvent water molecules which may affect the TtPRODH-TtP5CDH interface. Overall, 
our results provide evidence that the two-step oxidation of proline to glutamate catalyzed 
by PRODH and P5CDH from Thermus thermophilus involves a channeling mechanism. 
This study lays the groundwork for testing substrate channeling in other monofunctional 
PRODH and P5CDH such as the human enzymes. TtPRODH and TtP5CDH will also 
serve as a model for investigating substrate channeling between other individual enzymes 
that catalyze consecutive reactions.   
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CHAPTER 3 
                                                      
Purification and Characterization 
of Put1p and Put2p from 
Saccharomyces cerevisiae 
 
Note: This chapter contains results published in the research article: “Purification and 
characterization of Put1p from Saccharomyces cerevisiae.” Wanduragala S*, Sanyal N*, 
Liang X, Becker DF. Arch Biochem Biophys. 2010 Jun 15;498(2):136-42.  (*Equal 
contribution). Permission for usage in thesis obtained from Elsevier B.V. 
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INTRODUCTION 
 The oxidative conversion of proline to glutamate involves two enzymes, a flavin 
dependent proline dehydrogenase (PRODH) and a NAD
+
-dependent ∆1-pyrroline-5-
carboxylate (P5C) dehydrogenase (P5CDH). PRODH and P5CDH help organisms 
respond to changes in the nutritional environment by initiating the breakdown of proline 
as a source for nitrogen, carbon, and energy [1-6]. In Saccharomyces cerevisiae, Put1p 
and Put2p are the corresponding PRODH and P5CDH enzymes, respectively (Scheme 1) 
[7]. In yeast and other eukaryotes, PRODH and P5CDH are localized in the mitochondria 
[8, 9]. PRODH catalyzes the first step of proline oxidation by generating P5C, an 
intermediate in the proline catabolic pathway (see Scheme 1).  The reaction involves two 
phases or two half-reactions. In the reductive half-reaction electrons are transferred from 
proline to the flavin adenine dinucleotide cofactor to form P5C. The second phase (i.e., 
oxidative half-reaction) of the catalytic cycle involves oxidation of reduced flavin 
(FADH2) to regenerate FAD. P5C is then hydrolyzed to γ-glutamic acid semialdehyde 
(GSA) which is subsequently oxidized by P5CDH to form glutamate and NADH.  
 
Scheme 1- Overview of proline catabolism in S. cerevisiae. 
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 Expression of the PUT1 and PUT2 genes in yeast is sensitive to proline levels and 
nitrogen quality. In the presence of preferred nitrogen sources such as glutamine and 
ammonia, PUT gene expression is repressed [10]. In nitrogen limiting environments, 
PUT1 and PUT2 expression is upregulated coinciding with derepression of the PUT4 
gene which encodes a proline specific transporter [10]. Activation of the PUT1 and PUT2 
genes is regulated by Put3p, a transcriptional regulator which directly senses proline and 
belongs to the Zn(II)2Cys6 protein family [11-13]. Binding of proline to Put3p leads to a 
20-fold activation of the PUT genes [12]. Put3p also induces small increases in PUT gene 
expression independently of proline in response to poor nitrogen sources [13]. The 
resulting Put3p activation of the PUT1 and PUT2 genes enables yeast to utilize proline as 
a nitrogen source in coordination with glutamate dehydrogenase (Gdh2p) which 
oxidatively deaminates glutamate to generate ammonia and α-ketoglutarate (Scheme 1) 
[10, 14].  
 Human PRODH (PRODH1), also known as proline oxidase (POX1), is of particular 
importance as it has been shown to have unique roles in regulating cell survival and 
apoptotic pathways [1, 15]. Expression of human PRODH is upregulated by the tumor 
suppressor p53 protein with increased PRODH activity leading to induction of cell death 
pathways and helping to prevent cancer progression [16, 17]. Using a mouse xenograft 
tumor model, Phang and colleagues recently showed that PRODH activity significantly 
reduces tumor formation [18]. The mechanism by which human PRODH contributes to 
apoptosis involves the generation of reactive oxygen species such as superoxide anions 
either directly at the enzyme active site or indirectly due to increased electron flux in the 
mitochondrial electron pathway.   
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 Although PRODH has important roles in energy metabolism, nitrogen utilization, and 
in mammals, the programmed cell death pathway, detailed information about the 
biochemical and structural properties of PRODH from a eukaryotic organism are still 
lacking. In bacteria, the best characterized PRODH enzymes from bacteria are the 
bifunctional PutA enzymes which encode PRODH and P5CDH on a single polypeptide 
and the monofunctional PRODH enzyme from Thermus thermophilus (TtPRODH) [19, 
20]. X-ray crystal structures of the PRODH domain of PutA from Escherichia coli 
(EcPutA) and TtPRODH show a common (βα)8 barrel fold with a noncovalently bound 
FAD cofactor [19-21].  Human PRODH and Put1p most likely share the same (βα)8 
barrel fold and sequence alignments with the bacterial enzymes show human PRODH 
and Put1p also share important residues for substrate and FAD binding [19].  
 To better understand PRODH and P5CDH enzymes from eukaryotic organisms, we 
sought to purify and characterize Put1p and Put2p from S. cerevisiae. Particular focus 
was given to the oxidative half-reaction of Put1p and its reactivity with molecular oxygen 
as it may provide insight into the physiological role of human PRODH in superoxide 
production and apoptotic signaling pathways. The direct electron acceptor for Put1p in 
the oxidative half-reaction has not been demonstrated but a functional mitochondrial 
respiratory chain is necessary for S. cerevisiae to utilize proline as a nitrogen source [8]. 
Based on steady state kinetics, we propose that Put1p directly couples proline oxidation 
to ubiquinone reduction in the electron transport chain. 
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EXPERIMENTAL PROCEDURES 
Materials 
Ubiquinone-1 (CoQ1), flavin adenine dinucleotide (FAD), nicotinamide adenine 
dinucleotide (NAD
+
), L-tetrahydro-2-furoic acid (L-THFA), succinic semialdehyde, 
phenazine methosulfate, guanidium hydrochloride, antibiotics and buffers were 
purchased from Sigma-Aldrich. 2,6-dichlorophenolindophenol (DCPIP), o-
aminobenzaldehyde (o-AB), isopropyl β-D-1-thiogalactopyranoside (IPTG),  sodium 
chloride and Tris-HCl were purchased from Fisher Scientific Inc. L-proline was 
purchased from Acros Organics Ltd. All other chemicals and buffers were purchased 
from Sigma-Aldrich, Inc.  Molecular size standards used for calibrating size exclusion 
columns were purchased from Sigma.  Bicinchoninic acid (BCA) reagent used for protein 
quantitation was obtained from Pierce.  All experiments used Nanopure water. D,L-P5C 
was chemically synthesized from DL-hydroxylysine as described previously by Williams 
and Frank and stored in 1M HCl at 4
o
C [22]. D,L-P5C contains equimolar concentration 
of D-P5C and L-P5C.     
Constructs 
The PUT1 and PUT2 clones were a generous gift from Dr. Marjorie Brandriss at the 
University of Medicine and Dentistry of New Jersey-New Jersey Medical School [23]. 
The genes were expressed from a pET14b expression vector containing N-terminal 6x his 
tag. Put1p protein lacked the 18 residue mitochondrial signaling peptide (Put1p18). 
Put2p was expressed as a full-length protein. 
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Purification and characterization of Put1p and Put2p 
Put1p18 and Put2p were expressed and purified from E. coli strain BL21(DE3) 
pLysS with a N-terminal 6xHis tag using the pET14b expression vector as described 
here. The pET14b-PUT118 and pET14b-PUT2 constructs were transformed into E. coli 
BL21(DE3) pLysS. Transformed cells were plated onto Luria-Bertani (LB) agar 
containing chloramphenicol (34 μg/ml) and ampicillin (50 μg/ml). Resulting colonies 
were inoculated in 5 ml of LB broth containing the necessary antibiotics and grown to an 
optical density at 600 nm (OD600) of 1.0. 1 ml of the LB culture was then used to 
inoculate 1 L of Terrific Broth media containing chloramphenicol (34 μg/ml) and 
ampicillin (50 μg/ml).  The 1 L cultures were incubated at 37oC with shaking (250 rpm) 
until OD600 of 0.8 at which point Put1p expression was induced with 0.5 mM IPTG 
overnight at 20
o
C.  
The overnight cultures were centrifuged at 6000 rpm for 20 min at 4
o
C. The resulting 
pellets were resuspended in a final 50 ml volume of binding buffer (20 mM Tris, 5 mM 
imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) supplemented with protease inhibitors (3 
mM ε-amino-N-caproic acid, 0.3 mM phenyl methyl sulfonyl chloride, 1.2 μM leupeptin, 
48 μM N-p-tosyl-L-phenyl alanine chloromethyl ketone, 78 μM N-α-tosyl-L-lysine 
chloromethylketone). Additionally, 1 mM FAD and 0.5% n-octyl-β-D-glucoside was 
supplemented for Put1p purification. The cell suspension was disrupted by sonication at 
4
o
C for a total of 5 min (5 sec pulse on, 15 sec pulse off, 40% power). The cell extract 
was centrifuged at 16000 rpm (4
o
C) for 60 min. The supernatant (50 ml) was passed 
through a 0.8 μm filter (VWR) and applied to a Ni-NTA superflow (Qiagen) resin (25 ml 
bed volume in a 2.8 cm x 30 cm column) equilibrated with 1X binding buffer. Wash 
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buffer (125 ml, 20 mM Tris, 60 mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) was 
then applied to the column followed by elution buffer (20 mM Tris, 500 mM imidazole, 
0.5 M NaCl, 10% glycerol, pH 7.9) with a flow rate of 3 ml/min to elute protein fractions. 
Fractions from the elution step were then analyzed by SDS-PAGE and pooled. Pooled 
Put1p was then dialyzed into 50 mM Tris buffer (pH 8.1) containing 10% glycerol and 
concentrated using an Amicon 30-kDa cutoff filter (Millipore). Put2p was dialyzed into 
50 mM Tris buffer (pH 7.9) containing 25% glycerol. 
The molar ratio of flavin to Put1p polypeptide was estimated by denaturing Put1p in 6 
M guanidinium chloride. The spectrum was recorded from 600 to 250 nm. The total 
amount of polypeptide was determined using the molar extinction coefficient of 
denatured Put1p at 280 nm (A280= 45060 M
−1
cm
−1
) estimated by the ProtParam tool 
(ExPASy Proteomics Server). The amount of flavin was determined using the molar 
extinction coefficient for free FAD at 450 nm (A450= 11700 M
−1
 cm
−1
) in guanidinium 
chloride [24]. The molar extinction coefficient of flavin bound to Put1p was estimated to 
be 10800 M
−1
 cm
−1
 at 451 nm. The concentration of total Put1p protein was determined 
using the BCA method [25] while the concentration of flavin-bound Put1p was 
determined using the molar extinction coefficient for bound FAD (A451 = 10800 M
−1
 
cm
−1
). 
The oligomeric size of Put1p and Put2p were estimated using gel filtration 
chromatography. Superdex-200 10/300 GL prepacked column (GE Healthcare) was 
equilibrated with running buffer (50 mM Tris, pH 8, 150 mM NaCl). Purified Put1p and 
Put2p were diluted to a concentration of 2 mg/ml in a volume of 250 µL in running 
buffer. All samples and standards were spun at 10,000 rpm for 5 min prior to applying on 
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column. The proteins were individually applied on the Superdex-200 column with a flow 
rate of 0.5 ml/min at 4
o
C on a BioRad Biologic purification system (Lab of Dr. Joseph 
Barycki, University of Nebraska-Lincoln). Elution of fractions was analyzed using A280 
nm detection.  
Steady-state kinetic measurements   
Put1p kinetics  
 Put1p activity was measured at 25
o
C using terminal electron acceptors DCPIP, 
oxygen and CoQ1. The concentrations of Put1p used for all of the kinetic assays are based 
on the amount of flavin-bound Put1p. Proline:DCPIP oxidoreductase assay was 
performed as described in a 1-ml reaction volume using Cary 100 and Cary 50 UV-
visible spectrophotometers [26]. The DCPIP assay mixture contained 0.05 μM of Put1p 
enzyme, 0.27 mM phenazine methosulfate, 75 μM DCPIP and proline concentrations 
ranging from 0 to 300 mM in 20 mM Tris at pH 8.0. The rate of DCPIP reduction was 
measured at 595 nm (ε = 16100 cm-1 M-1) [26]. Proline:O2 oxidoreductase activity (1 ml 
assay volume) was measured in air saturated potassium phosphate buffer (50 mM, pH 
8.0) using 1 μM Put1p, 4 mM o-AB and 0-300 mM proline at 443 nm by following the 
formation of the o-AB-P5C yellow complex (ε = 2590 cm-1 M-1) [27]. Oxygen utilization 
by Put1p was also measured using a Clark type Pt,Ag/AgCl-electrode. The reaction 
mixture contained 2.2 µM Put1p and 300 mM proline in 50 mM phosphate buffer at pH 
8.0 (25 °C).  
 CoQ1 reduction was measured using 0.1 μM Put1p in 50 mM phosphate buffer at pH 
8.0 with 0-300 mM proline and 0-100 µM CoQ1. Reduction of CoQ1 was followed at 275 
nm (ε= 13700 cm-1 M-1) using a 0.15 cm path length on a Hi-Tech Scientific SF-61DX2 
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stopped-flow instrument at 25
o
C [28].  The kinetic parameters Km and kcat were estimated 
by regression analysis of the initial reaction velocity versus proline concentration using 
the Michaelis-Menten equation and Lineweaver-Burk plot analysis [29].  The binding 
order of the Put1p proline:CoQ1 oxidoreductase reaction was evaluated using double 
reciprocal plots of reaction velocity versus variable substrate concentrations. Assays were 
performed in 50 mM potassium phosphate (pH 8.0) using 0. 2 µM Put1p and with proline 
concentrations varied from 5-150 mM and CoQ1 concentrations varied 5-60 µM. Using 
global curve fit analysis in SigmaPlot 11 software, data was fitted to a classical ping-
pong mechanism (Equation 3.1).      
   
    [ ][ ]
   [ ]     [ ]   [ ][ ]
                     
 
Inhibition studies with L-THFA were performed using the DCPIP assay as described 
previously [30]. For these assays, proline concentrations were varied from 0 – 200 mM 
and the final L-THFA concentrations were varied from 0 – 6 mM using 100X stock 
solutions of L-THFA in 50 mM Tris buffer (pH 8.0). The inhibition constant (Ki) for L-
THFA was estimated by Dixon plot analysis [31].  For all of the above experiments, the 
initial velocity values were the average from assays performed in duplicate or triplicate. 
Proline titration of Put1p  
Proline titrations of Put1p were performed at 20 °C in 50 mM Tris buffer (pH 8.0) 
containing 50 mM NaCl and 10% glycerol under anaerobic conditions. The Put1p-proline 
mixtures were equilibrated 5 min after each addition of proline prior to recording each 
spectrum on a Cary 100 spectrophotometer. A correction for turbidity that occurred 
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during the experiment was applied by subtracting a light scattering spectrum. The amount 
of turbidity in each spectrum was determined by measuring the increase in absorbance at 
700 nm due to scattering. The titration data were analyzed as previously described 
assuming the formation of a reduced PutA-P5C complex [26, 32]. Although P5C is 
hydrolyzed to the open GSA form, the ring and open chain forms are rapidly reversible 
with P5C favored at pH > 7.0, indicating that P5C will be the predominant form at pH 8.0 
[33]. 
Put2p kinetics  
Put2p activity was measured by monitoring the formation of NADH at 340 nm (ε = 
6400 cm
-1
 M
-1
[34]) at 25 °C. The assay buffer contained 50 mM potassium phosphate 
(pH 7.5) and 25 mM NaCl. Put2p enzyme concentration was 0.4 µM (25.6 g/ml) and 
NAD
+
 concentration was 0.2 mM. Varying concentrations of L-P5C ranging from 1 to 
300 µM were used. Steady-state kinetics was also performed using 2-100 mM succinic 
semialdehyde as an alternative substrate. Initial rates were fitted to a Michaelis-Menten 
equation (equation 3.2).    
  
    [ ]
   [ ]
                      
pH dependence of Put1p and Put2p activity 
The pH optimum for Put1p and Put2p activity was determined using a mixed buffer 
system from pH 6.0–9.0 comprised of 20 mM each HEPES, MES, MOPS and TAB (80 
mM total). Put1p activity was measured by Proline:DCPIP oxidoreductase assay using 
0.1 µM Put1p and 220 mM proline. Put2p activity was measured by monitoring NADH 
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formation as described above except using 0.27 µM Put2p and 70 µM L-P5C. Data were 
fit to the equation : 
 
     
    
                       
            
 
where vlim is the limiting velocity (µmol/min) and pKa1 and pKa2 represent the acidic and 
alkaline ionizations that contribute to the pH dependent curve of the reaction velocity.  
RESULTS 
Molecular properties of Put1p and Put2p 
 Purified Put1p lacking the N-terminal residues 1-18 (Put1p18) was shown by SDS-
PAGE to have an apparent molecular weight of 50 kDa (Figure 1A) which nearly 
matches the predicted molecular weight of 53665 Da for the product of the N-terminal 
6xHis Put1p18 construct. SDS-PAGE analysis showed that purified Put2p had an 
apparent molecular weight of 64 kDa which is similar to its predicted molecular weight 
of 64304 Da (Figure 1B). The oligomeric states of Put1p and Put2p were studied using 
gel filtration chromatography. Figure 1C shows the elution profile of the two proteins. 
Calculated molecular weight of Put1p in solution is 1,229,316 Da. Such a high molecular 
weight is suggestive of aggregate formation in solution. The molecular weight of Put2p 
was estimated to be 265,292 Da and is indicative of a tetramer in solution. 
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Figure 1- Analysis of molecular weight of purified Put1p and Put2p. SDS-PAGE 
analysis of A) Put1p (3 µg) and B) Put2p (15 µg) each purified from E. coli. Predicted 
molecular weights of Put1p and Put2p are 53665 Da and 64304 Da, respectively. C) 
Analysis of the oligomeric size of Put1p (solid black trace) and Put2p (solid blue trace) 
by gel filtration chromatography. Using a plot of log10[molecular weight] versus elution 
volume of molecular weight standards, the estimated oligomeric size of Put1p and Put2p 
were 1,229,316 Da and 265,292 Da. For the molecular weight, Put1p is expected to be 
aggregated in solution and Put2p is expected to be a homotetramer. Molecular size 
standards are indicated as dotted curve. 1-thyroglobulin (Mr 669,000 Da), 2-ferritin (Mr 
440,000 Da), 3-bovine serum albumin (Mr 67,000 Da), 4-carbonic anhydrase (Mr 29,000 
Da) and 5-RNase A (Mr 13,700 Da).  
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Kinetic characterization 
 The UV-visible spectrum of Put1p is shown in Figure 2. Absorption maxima are at 
355 and 450 nm with a shoulder at 478 nm and are indicative of a bound FAD cofactor to 
the Put1p protein. (Figure 2, Inset A). Quantitation of the polypeptide at 280 nm and the 
flavin at 451 nm indicates a flavin/polypeptide ratio of 0.43. The flavin/polypeptide ratios 
varied from 0.3–0.45 between different preparations. Thus, recombinant Put1p contains a 
significant amount of the apo-form. Addition of proline to Put1p resulted in reduction of 
the flavin cofactor in a concentration dependent manner (Figure 2, Inset B). No anionic 
semiquinone was observed indicating flavin semiquinone is not stabilized during proline  
 
Figure 2- Spectral properties of purified Put1p.  Put1p in 20 mM Tris–HCl buffer (pH 
8.0) containing 100 mM NaCl and 0.25% octyl-glucoside. Concentrations of total and 
flavin-bound Put1p protein are 16.1 and 7 μM, respectively. Inset A, flavin spectrum 
from 550 to 300 nm of the same Put1p protein shown below. Inset B, titration of Put1p 
(3.8 μM flavin-bound form) with proline in 50 mM Tris–NaCl buffer (pH 8.0). Curves 1–
5 are selected spectra from the titration at 0, 0.01, 0.200, 1.0, and 5 mM proline. Inset C, 
best fit analysis of the absorbance decrease at 451 nm during the titration with proline 
assuming the formation of a Put1p–P5C complex from which a Keq of 1.4 mM
−1
 proline 
was estimated. 
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reduction. 50% of the FAD in Put1p was reduced at 0.7 mM proline as estimated from 
the plot shown in Figure 2 (Inset C).  
 Kinetic parameters for Put1p using the proline:DCPIP oxidoreductase assay were Km 
= 36 ± 5 mM proline and kcat = 27 s
-1
. The Km value is similar to that reported for the 
monofunctional TtPRODH enzyme (Km = 27 mM proline, kcat = 13 s
-1
) but the turnover 
number is about 2-fold higher [20]. For PutA enzymes, Km values range from 100-150 
mM proline with turnover numbers around 5-12 s
-1
 [35]. The kinetic parameters for Put1p 
along with TtPRODH may indicate that monofunctional enzymes generally exhibit 
higher turnover numbers and a lower Km values for proline than bifunctional PutA 
enzymes.   
 Put2p kinetic parameters measured by NADH reduction indicate a Km of 104.2 ± 4.4 
µM L-P5C and a turnover number (kcat) of 1.49 ± 0.26 sec
-1
. In comparison Thermus 
thermophilus P5CDH has a Km of 42.7 ± 1.1 µM L-P5C and kcat of 0.52 ± 0.03 sec
-1 
(Chapter 2) and Human P5CDH has a Km of 31.6 ± 7.9 µM L-P5C and kcat of 10.0 ± 0.9 
sec
-1 
 [34]. 
pH dependence of Put1p and Put2p activity 
 The pH optimum for the Put1p reaction was determined by following proline:DCPIP 
oxidoreductase activity over the pH range 6–9. Figure 3 shows a symmetrical and bell-
shaped curve for Put1p activity with a pH optimum of 8.25. By fitting the data to 
equation 3.3, pKa values of 7.54±0.09 (pKa1) and 9.18±0.13 (pKa2) were estimated for the 
two ionization events observed in the pH dependence of Put1p activity. Over a pH range 
of 6-9, activity of Put2p also exhibited a symmetrical bell-shaped curve. However, a 
more acidic pH optimum for Put2p activity was observed. The peak activity was seen at 
7.15 and pKa values of 6.03±0.13 (pKa1) and 8.31±0.11 (pKa2) were estimated for the 
ascending and descending limbs of the curve, respectively. 
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Figure 3- pH profiles of Put1p and Put2p enzymatic activity. The pH profile for the 
Put1p reaction (black open circles) was determined by following proline:DCPIP 
oxidoreductase activity using 0.1 µM Put1p and 220 mM proline over the pH range 6–9 
at 25°C. Put2p activity was measured by NADH formation assay using 0.27 µM Put2p 
and 70 µM L-P5C (blue closed circles). The pKa values for Put1p and Put2p were 
estimated by fitting the data to equation 3.3. pKa values of 7.54±0.09 (pKa1) and 
9.18±0.13 (pKa2) with a pH optimum of 8.25 were estimated for Put1p (black curve).  
Put2p was estimated to have peak activity at 7.15 and pKa values of 6.03±0.13 (pKa1) and 
8.31±0.11 (pKa2) (blue curve). pKa1 and pKa2 are the ionization constants for two 
ionizable groups that influence the observed pH dependence of Put1p and Put2p activity. 
 
Substrate specificity and inhibition 
 The ability of Put1p to use alternative substrate trans-4-hydroxy-L-proline and was 
tested. Only very low activity (0.008 U/mg) was observed with 4-hydroxy-L-proline 
which is more than 2000-fold lower than the specific activity of Put1p with proline (18 
U/mg). ). Put1p also exhibited very low activity (0.004 U/mg) with L-pipecolic acid and 
no activity with D-proline. Thus Put1p has strong substrate specificity for L-proline. 
 A potent inhibitor of PRODH activity is L-THFA, an isostructural analog of proline. 
Previously, TtPRODH was shown to be inhibited by L-THFA with a Ki of 1 mM [20]. 
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Figure 4 shows a Dixon plot analysis of the inhibition of Put1p activity by L-THFA. The 
plot is consistent with L-THFA acting as a competitive inhibitor of Put1p with a Ki of 5.5 
mM. Most likely L-THFA binds to the active site of Put1p similarly to that observed in 
the X-ray crystal structures of the E. coli PRODH domain complexed with L-THFA [36].  
 
Figure 4- Inhibition of Put1p activity by L-THFA. A Ki value of 5.5 mM THFA was 
estimated by Dixon plot analysis of the reaction velocity versus L-THFA at various 
proline concentrations (0-200 mM).  
  
 The substrate for Put2p is open-chained GSA which is in a non-enzymatic 
equilibrium with cyclic P5C. We wanted to test Put2p activity using an obligate open-
chain substrate such as succinic semialdehyde. Put2p exhibits a 15000-fold lower kcat/Km 
with succinic semialdehyde (kcat/Km = 0.974 M
-1
 s
-1 
) relative to P5C/GSA (kcat/Km = 
14900 M
-1
 s
-1
)   Thus,  succinic semialdehyde is a relatively poor substrate for Put2p.  
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Oxidative half-reaction 
 Because upregulation of human PRODH1 (or POX) activity leads to the formation of 
reactive oxygen species and has important roles in apoptosis, we sought to characterize 
the reactivity of Put1p with oxygen.  The reactivity of  Put1p with molecular oxygen or 
oxidase activity was evaluated at different proline concentrations in air-saturated buffer 
by monitoring P5C production with o-AB. Kinetic parameters for Put1p oxidase activity 
were kcat = 0.8 min
-1
 and Km = 50 mM proline (Figure 5).  
 
Figure 5- Estimation of kinetic parameters using different electron acceptors. The 
electron acceptors considered for catalytic turnover of Put1p were DCPIP, CoQ1 and 
oxygen. Kinetic parameters for proline as substrate were measured using 75 μM DCPIP 
(▼), 100 µM CoQ1(●) or air-saturated reaction buffer (○, Inset). The initial rates were 
fitted to a Michaelis-Menten equation. The Km for proline using these electron acceptors 
was comparable (36 mM, 59 mM and 50 mM for DCPIP, CoQ1, and oxygen 
respectively). kcat for Put1p using artificial electron acceptor DCPIP and CoQ1were 27.6 
sec
-1 
and 13.4 sec
-1
. Put1p exhibited negligible turnover using molecular oxygen (kcat = 
0.013 sec
-1
).  
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Put1p displayed similar activity in assays using an O2 electrode in which Put1p depleted 
oxygen at a rate of 0.54 min
−1
. The turnover number with molecular oxygen is 15-fold 
lower for Put1p than TtPRODH (12 min
-1
) [20].  
 The Put1p oxidative half-reaction was then characterized using CoQ1 as the electron 
acceptor. The kcat and Km values determined with CoQ1 were 20 ± 1 s
-1
 and 57 ± 6 µM, 
respectively. The kinetic parameters for proline with CoQ1 concentration held constant 
(100 µM) were estimated to be kcat = 13.4 ± 0.2 s
-1 
and Km = 59 ± 3 mM proline. The high 
turnover rate of Put1p with CoQ1 suggests ubiquinone is the most likely the physiological 
electron acceptor for Put1p. The order of the reaction was then analyzed by varying 
proline concentration at different CoQ1 concentrations. Figure 6 shows double reciprocal 
plots of the reaction velocity versus proline (Figure 6A) and CoQ1 (Figure 6B). The data 
in both plots could be fit with parallel slopes indicating a ping-pong mechanism (Scheme 
2) in which no ternary complex is required during catalytic turnover with proline and 
ubiquinone.  
 
Figure 6- Binding order analysis of Put1p with proline and CoQ1. Panel A shows a 
double reciprocal plot of velocity versus proline at four different CoQ1 concentrations (5, 
10, 20, and 60 µM). Panel B shows a double reciprocal plot of velocity versus CoQ1 at 
four different proline concentrations (5, 20, 50, and 150 mM). Assays were performed in 
50 mM potassium phosphate (pH 8.0) at 25
o
C. Data were fit by global curve fitting to a 
linear polynomial equation with a shared slope parameter (R
2
 values of 0.95 and 0.97).  
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Scheme 2- Schematic representation of binding order of CoQ1 and proline with 
Put1p 
DISCUSSION 
 Sequence comparisons among bacterial PutA/PRODHs, Put1p, and human PRODH 
predict that a number of residues important for substrate and FAD binding in the PRODH 
catalytic core are conserved [20]. The sequence similarity between Put1p (476 amino 
acids) and the PRODH domain of EcPutA (1-669 residues) is 39%. Put1p and human 
PRODH1 have 25% sequence identity and 41% similarity consistent with a shared 
PRODH domain and a catalytic core structure. Nine conserved motifs important for 
substrate (1-3, 7-9) and FAD binding (4-6) have been identified in the PRODH domain of 
bacterial PutA and monofunctional PRODH enzymes [20]. Of these, motifs 3, 8, and 9 
are strongly conserved in Put1p. Figure 7 shows a sequence alignment of motifs 3, 8 and 
9 in Put1p and EcPutA. Conserved residues in these motifs which are critical for proline 
binding in EcPutA include Asp370, Tyr540, Arg555, and Arg556 (Asp257, Tyr430, 
Arg445, and Arg446 in Put1p). Important residues for FAD binding are also conserved in 
Put1p. These residues are found in motifs 4-6 and in EcPutA include Gln404 (Gln 294, 
Put1p) that forms a hydrogen bond with the FAD O(2), Arg431 which hydrogen bonds to 
the N(5) of FAD (K321, Put1p), and His487 (His377, Put1p) that interacts with the FAD 
pyrophosphate [20].  Another important residue for FAD binding in EcPutA is Glu559 
EOX (EOX Pro = ERED●P5C)         ERED (ERED●Q1OX = EOX●Q1RED )          EOX
Proline                                         P5C             Q1OX Q1RED
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(motif 9) which hydrogen bonds to the ribityl 3′-OH and is conserved in Put1p 
(Glu449). Lastly, Put1p is predicted to have the α5a helix that is a unique feature of the 
(βα)8 barrel in EcPutA. In EcPutA, Trp438 (motif 5) from the α5a helix stacks against the 
adenine ring of the FAD. The corresponding residue in Put1p is Ile328 which would 
serve a similar purpose of providing non-polar interactions with the adenine ring.  
 
 
Figure 7- Alignment of PRODH domain sequence motifs between E. coli PutA 
(EcPutA), Human PRODH (hPRODH1) and Put1p. Conserved residues with critical 
roles in proline and FAD interactions as mentioned in the text are underlined. Alignment 
was performed using GeneDoc software and the EcPutA (AAB59985), hPRODH1 
(NP_057419.4), and Put1p (NP_013243) sequences. 
 
 Put1p activity with other secondary amine compounds was tested to explore how 
strongly L-proline is the preferred substrate. Humans have two PRODH enzyme forms 
that share 45% sequence identity, PRODH1 (NM_016335) which is specific for L-
proline, and PRODH2, (NM_021232) which is specific for trans-4-hydroxy-L-proline. 
PRODH2 (OH-PRODH) catalyzes the oxidation of trans-4-hydroxy-L-proline to ∆1-
pyrroline-3-hydroxy-5-carboxylate [37, 38]. ]. Humans also have the enzyme, L-
pipecolic acid oxidase, which converts L-pipecolic acid to Δ1-piperideine-6-carboxylic 
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acid. Because S. cerevisiae encodes only one PRODH gene, we were interested to see 
whether Put1p exhibited a broad substrate specificity that could accommodate variations 
in the five-membered pyrrolidine ring.   
 Conserved among all bacterial PutA/PRODH enzymes is an active site Tyr residue 
(Tyr540 in EcPutA) that helps shape the proline binding site [37]. Interestingly, human 
PRODH1 and HO-PRODH differ at this corresponding residue with the Tyr replaced by 
a smaller Ser residue in HO-PRODH [37]. Recently, Ostrander et al. provided evidence 
that Tyr540 in EcPutA imposes spatial constraints in the active site that determines the 
preference for proline over hydroxyproline [37]. Substitution of Tyr540 with Ser or Ala 
in EcPutA decreased the preference for proline by > 20-fold suggesting the corresponding 
Ser residue in HO-PRODH allows utilization of both proline and hydroxyproline [37]. As 
noted above Put1p is predicted to share the corresponding Tyr residue (Tyr430, motif 8) 
found in bacterial PutA/PRODH enzymes and human PRODH1. Accordingly, Put1p 
exhibits a strict preference for proline over hydroxyproline (2000-fold) consistent with 
the active site Tyr residue helping to define substrate specificity. Other lower organisms 
that lack a specific OH-PRODH enzyme, have hydroxyproline epimerases that catalyze 
the conversion of hydroxy-L-proline to hydroxy-D-proline [38-40]. Hydroxy-D-proline is 
then oxidized to ∆1- pyrroline-4-hydroxy-2-carboxylate by hydroxy-D-proline oxidase 
[38-40]. S. cerevisiae does not contain this pathway for hydroxyproline. The ability of 
microorganisms to utilize hydroxy-L-proline can provide important metabolic advantages 
in pathogen- and symbiotic-host interactions in mammals and plants [38-41]. Recently, a 
hydroxyproline transport system was identified in the soil microbe Sinorhizobium 
meliloti, the first to be described in a prokaryote [41].  
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 Succinic semialdehyde is four-carbon aldehyde that lacks an α–amino group. 
Upon testing the possibility of succinic semialdehyde as a substrate for Put2p, we found 
that Put2p exhibits a 15000-fold lower catalytic efficiency relative to P5C/GSA. Analysis 
of T.thermophilus P5CDH structure with glutamate bound to the active site (PDB ID: 
2BHQ) reveals several possible ionic interactions of the α-carboxylate and amine groups 
of glutamate with residues in the TtP5CDH active site. The α-carboxylate group of 
glutamate is 3 Å from the backbone amide nitrogen of Gly 477 and Ala 488. The α-
carboxylate moiety is also within hydrogen bonding distance (2.7 Å) to Ser 323. These 
active site residues appear to be well conserved in Put2p and other P5CDH’s including 
human P5CDH and bifunctional PutA from Bradyrhizobium japonicum. Similar 
interactions might be possible in the Put2p active site. Shortage of one carbon atom in the 
aliphatic succinic semialdehyde may lead to lack of stabilizing interactions in the active 
site, thereby allowing Put2p to select appropriate substrate for the proline oxidative 
pathway. 
 The oxidative half-reaction of Put1p was investigated to provide molecular insights 
into the mitochondrial functions of human PRODH. A comparison of the Put1p and 
human PRODH1 sequences reveals a 25% sequence identity (41% similarity) consistent 
with a shared (βα)8 PRODH domain and a catalytic core structure. Put1p exhibited low 
reactivity with molecular oxygen and high activity with ubiquinone during catalytic 
turnover with proline. How adequately these results address the properties of human 
PRODH are not yet clear. Despite a high degree of similarity, Put1p and human PRODH 
may have fundamental differences in the oxidative half-reaction step. The ability of 
human PRODH to contribute to both mitochondrial energetics and apoptosis may be a 
94 
 
 
key distinctive feature of this enzyme. Human PRODH may have significant reactivity 
with molecular oxygen which would explain its role in generating mitochondrial reactive 
oxygen species and apoptosis.  A useful comparison that has been used to describe 
PRODH reactivity in air is the ratio of the turnover numbers from the proline 
oxidoreductase assays using DCPIP and oxygen as electron acceptors (DCPIP/O2). The 
DCPIP/O2 activity ratio for Put1p is > 2000 and is similar to the value for EcPutA (> 
2500). In contrast, TtPRODH has a DCPIP/O2 activity ratio of 61 indicating less 
preference for DCPIP over oxygen. Also, PutA from Helicobacter pylori was reported to 
have a DCPIP/O2 activity ratio of 16 [42]. Structural insights into the variation of oxygen 
reactivity among PutA/PRODH enzymes are still lacking but the differences in oxygen 
reactivity observed among PRODH enzymes is likely a consequence of diverse 
environmental niches and unique physiological roles for proline metabolism such as the 
programmed cell death pathway in mammals.  
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CHAPTER 4 
                                                      
Studying the effect of solvent pH on 
channeling of intermediate Δ1–
pyrroline-5-carboxylate in PutA 
from Bradyrhizobium japonicum  
 
Note:  This chapter contains methodology published in the research article: “Crystal 
structure of the bifunctional proline utilization A, flavoenzyme from Bradyrhizobium 
japonicum.” Srivastava D, Schuermann JP, White TA, Krishnan N, Sanyal N, Hura GL, Tan A, 
Henzl MT, Becker DF, Tanner JJ. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2878-83.   
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INTRODUCTION 
Proline utilization A (PutA) from Bradyrhizobium japonicum (BjPutA) is a 
bifunctional enzyme containing two catalytic domains- proline dehydrogenase (PRODH) 
and ∆1-pyrroline-5-carboxylate dehydrogenase (P5CDH) [1]. This type of multi-domain 
organization of proline catabolic enzymes in B. japonicum is also observed in other 
Gram-negative bacteria [2]. The oxidation of proline to glutamate is catalyzed in 
consecutive reactions by PRODH and P5CDH (Scheme 1). In the first step, proline 
dehydrogenase (PRODH; EC 1.5.99.8) uses a flavin adenine dinucleotide (FAD) cofactor 
as an electron acceptor to remove two electrons from proline, rendering the intermediate 
∆1-pyrroline-5-carboxylate (P5C).  P5C then undergoes a non-enzymatic hydrolysis, 
which opens the ring structure and generates γ-glutamate semialdehyde (GSA).  P5C 
dehydrogenase (P5CDH; EC 1.5.1.12) next pulls off two additional electrons from GSA 
using nicotinamide adenine dinucleotide (NAD
+
) to complete the conversion of proline to 
glutamate [3].  Avoiding release of P5C/GSA into bulk solvent during proline oxidation 
may be beneficial due to the chemical properties of P5C/GSA as discussed in Chapter 1.   
 
Scheme 1 – Reactions catalyzed by the PRODH and P5CDH domains of BjPutA  
 
Recently, Srivastava et al reported a 2.1 Å resolution crystal structure of BjPutA 
(999-residue polypeptide) that reveals an interior channel connecting the PRODH and 
P5CDH active sites [4] (PDB ID: 3HAZ) (Figure 1A). Supporting kinetic studies have 
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demonstrated that BjPutA transfers the intermediate P5C/GSA from the PRODH active 
site to the P5CDH active site. The dimeric structure of BjPutA seems to be critical for 
sealing the channel and minimizing access to bulk solvent. A β-flap protrudes from the 
P5CDH domain (β-strands, residues 628-646 and 977-989) from one protomer and forms 
intermolecular interactions with the P5CDH domain of the second protomer (Figure 1B).  
 
Figure 1- Overall structure of dimeric BjPutA and structural role of the C-terminal 
β-flap region. A) Ribbon representation of dimeric BjPutA. The PRODH domain (red) 
and the P5CDH domain (orange) of each protomer are connected by a linker region 
(green). Active site residues (Arg456, Cys792), FAD and NAD
+
 are displayed as sticks. 
-flap of each protomer is colored as magenta. The substrate channel of each BjPutA 
protomer is shown as a blue surface. B) Close-up view of the dotted section of the dimer 
showing the C-terminal region of the β-flap. C) Surface representation of the β-flap 
region showing potential openings that lead to the internal channel of BjPutA. The 
figures were made using PyMol [5] and PDB ID: 3HAZ. 
 
Figure 1C shows that in BjPutA the β-flap not only helps stabilize dimer 
formation but is also important for sealing the central cavity. There appears to be two 
adjacent openings near the β-flap that may allow access between external solvent and the 
internal channel. To study the extent to which the substrate channel is closed off from 
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bulk solvent for transfer of P5C and its hydrolysis to GSA, we used a truncated variant of 
BjPutA. Residues 987-999 of the C-terminal region of the β-flap were deleted to test 
whether bulk solvent access to the channel could be increased (Scheme 2). The truncated 
BjPutA 1-986 mutant is expected to exhibit less channeling of P5C/GSA due to 
potentially increased exposure of the channel cavity to bulk solvent. The overall 
PRODH/P5CDH coupled reaction in the BjPutA 1-986 mutant may also become more 
sensitive to the bulk solvent environment (e.g., pH) relative to wild-type BjPutA. 
 
Scheme 2- Schematic representation of enzymes used for comparing substrate 
channeling in bifunctional enzymes.  E1 and E2 represent PRODH and P5CDH 
respectively. A, B and C represent proline, P5C/GSA and glutamate respectively. 
 
In the proline catabolic pathway, channeling of P5C/GSA may be important for 
making the hydrolysis of P5C to GSA more favorable at physiological pH values. The 
P5C/GSA equilibrium is highly pH dependent.  Bearne and Wolfenden have 
demonstrated by nuclear magnetic resonance that GSA is favored at pH < 6.6 due to 
protonation of the pyrrolinium ring, which facilitates the hydrolysis of P5C to GSA 
(Figure 2). Thus, one benefit of channeling between PRODH and P5CDH would be to 
increase the pKa of the pyrrolinium species above pH 6.6, making the hydrolysis of P5C 
E1 E2
A B C
Channeling
(Wild type BjPutA)
E1
A B
E2
B C
E1 E2
Non-channeling control
(Mixed Variants)
Cys 792 Ala
Arg 456 Met
E1 E2
A B C
Partial Channeling
(BjPutA 1-986 -flap mutant )
102 
 
 
 
to GSA more favorable at physiological pH conditions. If we only consider the P5C/GSA 
hydrolysis step, substrate channeling is likely more critical for the proline catabolic 
pathway than for proline biosynthesis, since P5C formation is favored at physiological 
pH. 
 
Figure 2- pH dependent hydrolysis of ∆1-pyrroline-5-carboxylate (P5C) to γ-
glutamate semialdehyde (GSA). Ratio of the hydrate of GSA to the imine of P5C as a 
function of pD obtained from a proton NMR spectra [6]. The pKa of the imine proton was 
calculated as 6.67 (±0.08). Figure adapted from [6]. 
 
To test this hypothesis, we examined the pH dependence of the coupled PRODH-
P5CDH reaction (channeling assay). Using proline as the substrate for the channeling 
reaction, we measured the P5CDH enzymatic rate (reflected by rate of NADH formation) 
and the transient time required to attain steady-state NADH formation under varying pH 
conditions. If the substrate channel provides a favorable condition for hydrolysis of P5C, 
the transient time for a channeling reaction should remain unaffected by external pH in 
the wild-type enzyme. BjPutA 1-986 is expected to be influenced by external pH to a 
greater extent due to more exposure of the substrate channel to bulk solvent than wild-
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type BjPutA. Because cyclic P5C is favored at pH above 6.6, the transient time for 
glutamate formation may to increase substantially for BjPutA 1-986 at higher pH values. 
We also used a non-channeling control which is an equimolar mixture of BjPutA active 
site mutants that lack PRODH (R456M) and P5CDH (C792A) activity [4]. The R456M 
mutation inactivates PRODH but does not impair P5CDH activity, whereas the C792A 
mutation inactivates P5CDH but does not impair PRODH activity. In this non-channeling 
control, P5C formed by the C792A variant must diffuse out into bulk solvent and bind to 
the R456M variant before NADH is formed. Hence, for the non-channeling control, the 
hydrolysis of P5C to GSA should be highly dependent on the pH of the bulk solvent.  
EXPERIMENTAL PROCEDURES 
Materials 
D,L-P5C was chemically synthesized from D,L-hydroxylysine as described 
previously by Williams and Frank and stored in 1 M HCl at 4
o
C [7]. Synthesized D,L-
P5C is an equimolar mixture of D-P5C and L-P5C. All chemicals were purchased from 
Sigma Aldrich unless noted otherwise. Tris(3-hydroxypropyl)phosphine (THP) was 
purchased from Santa Cruz Biotechnology Inc. CoQ1 reduction assays and substrate 
channeling assays were carried out on a SF-61DX2 stopped-flow spectrophotometer 
(TgK Scientific, UK). CoQ1 reduction assays for enzymatic activities of PRODH and 
P5CDH activity assays were carried out on a Cary-50 UV-Vis spectrophotometer 
(Varian) or Powerwave XS Microplate reader (BioTek). The pKA8H-BjPutA 1-986- 
construct was a generous gift from Dr. John tanner (University of Missouri, Columbia). 
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Purification of BjPutA and mutants 
Wild-type BjPutA, BjPutA mutants R456M, C792A and, BjPutA 1-986 C-terminal 
deletion mutant were expressed and purified from E. coli strain BL21(DE3) pLysS with 
an N-terminal 6xHis tag using the pKA8H expression vector [4]. The BjPutA-pKA8H 
constructs were transformed into E. coli BL21(DE3) pLysS. Transformed cells were 
plated onto Luria-Bertani (LB) agar containing chloramphenicol (34 μg/ml) and 
ampicillin (50 μg/ml). Resulting colonies were inoculated in 5 ml of LB broth containing 
the necessary antibiotics and grown to an optical density at 600 nm (OD600) of 1.0. 1 ml 
of the LB culture was then used to inoculate 1 L of LB Broth media containing 
chloramphenicol (34 μg/ml) and ampicillin (50 μg/ml).  The 1 L cultures were incubated 
at 37
o
C with shaking (250 rpm) until OD600 of 0.8 at which point protein expression was 
induced with 50 µM IPTG overnight at 20
o
C.  
The overnight cultures were centrifuged at 6000 rpm for 20 min at 4
o
C. The resulting 
pellets were resuspended in a final 50 ml volume of binding buffer (20 mM Tris, 5 mM 
imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) supplemented with 1 mM FAD and 
protease inhibitors (3 mM ε-amino-N-caproic acid, 0.3 mM phenyl methyl sulfonyl 
chloride, 1.2 μM leupeptin, 48 μM N-p-tosyl-L-phenyl alanine chloromethyl ketone, 78 
μM N-α-tosyl-L-lysine chloromethylketone). The cell suspension was disrupted by 
sonication at 4
o
C for a total of 5 min (5 sec pulse on, 15 sec pulse off, 40% power). The 
cell extract was centrifuged at 16000 rpm (4
o
C) for 60 min. The supernatant (50 ml) was 
passed through a 0.8 μm filter (VWR) and applied to a Ni-NTA superflow (Qiagen) resin 
(25 ml bed volume in a 2.8 cm x 30 cm column) equilibrated with 1X binding buffer. 
Wash buffer (125 ml, 20 mM Tris, 60 mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) 
was then applied to the column followed by elution buffer (20 mM Tris, 500 mM 
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imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) with a flow rate of 3 ml/min to elute 
protein fractions. Fractions from the elution step were then analyzed by SDS-PAGE and 
pooled. Pooled protein was then dialyzed into 50 mM Tris buffer (pH 7.9) containing 50 
mM NaCl, 0.5 mM EDTA, 0.5 mM THP, 10% glycerol and concentrated using an 
Amicon 100-kDa cutoff filter (Millipore) and stored in -80
o
C.  
The absorbance spectra of purified protein were recorded from 600 to 250 nm. The 
concentration of flavin was determined using the molar extinction coefficient for 
enzyme-bound FAD at 450 nm (A450= 13700 M
−1
 cm
−1
) [1]. Any unbound flavin was 
removed by passing purified protein through a PD-10 desalting column (GE Healthcare). 
The concentration of total protein was determined using Pierce 660 reagent [8]. The ratio 
of flavin concentration to protein concentration was used to determine the amount of 
BjPutA containing bound FAD. The concentration of FAD bound BjPutA was used as the 
concentration of BjPutA in the enzyme assays. 
Enzymatic assay of BjPutA and mutants 
PRODH kinetics 
Kinetics of the PRODH domain of BjPutA and its variants were determined by 
following the reduction of CoQ1. CoQ1 reduction was measured using 0.5 μM of BjPutA 
(wild-type BjPutA and mutants) in 50 mM phosphate buffer at pH 8.0. Kinetic 
parameters for proline were measured by varying proline (0-250 mM) with fixed CoQ1 
concentration (250 µM). Kinetic parameters for CoQ1 were measured by varying CoQ1 
(0-300 µM) with fixed proline concentration (150 mM). Reduction of CoQ1 was followed 
at 275 nm (ε=13700 cm-1 M-1) using a 0.15 cm path length on a Hi-Tech Scientific SF-
61DX2 stopped-flow instrument at 25
o
C [9].  The kinetic parameters Km and kcat were 
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estimated by regression analysis of the initial reaction velocity versus proline or CoQ1 
concentration using the Michaelis-Menten equation. The specific activity of PRODH 
with 40 mM proline as the substrate was determined by measuring P5C complex 
formation with o-aminobenzaldehyde (o-AB) [10]. P5C forms a yellow 
dihydroquinazolinium complex with o-AB, which is detected by absorbance at λ = 443 
nm (ε=2900 M-1cm-1 [10]). For this assay, wild type BjPutA (0.18 µM) or BjPutA 1-986 
(0.18 µM) was incubated with proline (40 mM), o-AB (4.0 mM) and 0.1 mM CoQ1 as an 
electron acceptor. The assays were performed at pH 6-10 using a mixed buffer system 
containing 50 mM potassium phosphate, 25 mM borate and 25 mM bicine buffer. Data 
were fit to the equation 4.1. 
     
    
                       
            
where vlim is the maximal velocity and pKa1 and pKa2 represent the acidic and alkaline 
ionizations that contribute to the pH dependent curve of the reaction velocity. 
P5CDH kinetics 
The P5CDH activity of wild-type BjPutA, BjPutA R456M and BjPutA 1-986 was 
measured by monitoring the formation of NADH at 340 nm (ε = 6400 cm-1 M-1 [4]) at 25 
°C. The assay buffer contained 50 mM potassium phosphate (pH 7.5), 25 mM borate and 
25 mM bicine. Enzyme concentration was 0.18 µM (20 µg/ml) and NAD
+
 concentration 
was 0.2 mM. Varying concentrations of L-P5C ranging from 1 -3.9 mM were used. Initial 
rates were fitted to the Michaelis-Menten equation. For obtaining pH profile of kinetic 
parameters, P5CDH activity assays were carried out in a mixed buffer system containing 
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50 mM potassium phosphate, 25 mM borate and 25 mM bicine buffer pH 6-10 was used. 
kcat/Km for P5CDH were fit to the equation 4.1. 
Substrate channeling assays at varying pH 
To determine the pH activity dependence of substrate channeling, NADH 
formation was monitored at 340 nm in assays performed at 23 °C containing proline (40 
mM), BjPutA (0.18 µM), CoQ1 (0.1 mM), and NAD
+
 (0.2 mM) in buffer containing 50 
mM potassium phosphate, 25 mM borate and 25 mM bicine (pH 6-10). Identical assays 
were performed using 0.18 µM (20 μg/ml) BjPutA 1-986 or an equimolar mixture of the 
BjPutA variants C792A and R456M (0.18 µM or 20 μg/ml final concentration each). 
Spectral interference caused by changes in CoQ1 absorbance at 340 nm was corrected for 
by subtracting progress curves from assays performed under identical conditions in the 
absence of NAD
+
.  
The progress curve for two non-interacting PRODH and P5CDH enzymes was 
simulated as described previously [11] for a diffusion-limited two-enzyme model using 
equations 4.2 and 4.3 
[    ]         (
  
  
)   ( 
 
   
     )                   
  
   
  
                 
In the above equation, v1 is the experimentally determined rate of PRODH activity under 
the specified assay conditions with 40 mM proline, t is time in sec, Km2 and v2 are the 
steady-state Michaelis-Menten constants for P5CDH activity in BjPutA wild-type and 
mutants, and τ is the transient time (sec) required to attain steady-state formation of 
108 
 
 
 
product (i.e., NADH). The transient time was also calculated by extrapolating the linear 
NADH formation rate to the x-axis. The x-intercept reflects the transient time required 
for reaching steady-state NADH formation. pH dependent changes in transient time were 
fitted to equation 4.4, 
      
               
       
           
                  
where Tobs represents the observed extrapolated transient time, Tlim1 and Tlim2 represent 
the limiting values for transient time at low and high pH respectively and pKa is the acid 
dissociation constant of an ionizable group in the pH range. 
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RESULTS 
Kinetic properties of wild-type BjPutA and its mutants 
Wild type BjPutA, BjPutA 1-986 and inactive mutants C792A and R456M were 
purified with over 90% protein bound to FAD in all cases. Each protein displays a typical 
UV-visible spectrum of protein bound FAD with maximum absorbance peaks at 384 and 
450 nm and a shoulder near 467 nm (Figure 3) [12].  
 
Figure 3- Absorbance spectra of purified BjPutA enzymes. Wild-type BjPutA, 
BjPutA 1-986, active site mutants C792A and R456M show similar flavin spectra. The 
shoulder at 467 nm is characteristic of flavin bound to the PRODH active site of BjPutA. 
 
The steady-state kinetic parameters of BjPutA wild-type and the mutants are 
reported in Table 1. The kinetic parameters for proline using CoQ1 as an electron 
acceptor are 28.6 ± 3.8 mM proline (Km) and 1.69 ± 0.06 sec
-1
(kcat). These values are 
similar to the previously reported parameters (Km = 31 ± 6 mM proline, kcat = 2.0 ± 0.1 
sec
-1
) for BjPutA [4]. BjPutA 1-986 was shown to have a Km of 40.6 ± 2.7 mM proline 
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and a two-fold higher kcat of 3.47 ± 0.07 sec
-1 
relative to wild-type BjPutA. The BjPutA 
mutant C792A also shows PRODH activity similar to wild-type BjPutA whereas the 
R456M mutant is devoid of PRODH activity (Table 1). 
CoQ1 has been shown to act as a potential physiological electron acceptor for the 
PRODH activity of E. coli PutA (EcPutA) [13], monofunctional PRODH from S. 
cerevisiae (Put1p) [14] and T. thermophilus (TtPRODH) (Chapter 2). Although CoQ1 has 
been previously used in assays with BjPutA [4], its steady-state kinetic parameters have 
not yet been determined. Here, we report that wild-type BjPutA has a Km of 83.63 ± 
13.41 µM CoQ1. In comparison, EcPutA has a Km of 110 ± 15 µM for CoQ1. 
Monofunctional PRODHs exhibit a somewhat wider range of Km values for CoQ1 with 
Put1p and TtPRODH having Km values of 57 ± 6 µM and 162.2 ± 7.6 µM CoQ1, 
respectively. The Km values for CoQ1 with BjPutA 1-986 (72.41 ± 4.96 µM) and BjPutA 
P5CDH inactive mutant C792A (103.01 ± 20.83 µM) are similar to wild-type BjPutA. 
Table 1 – Steady-state kinetic parameters of PRODH and P5CDH activities of 
BjPutA wild-type and mutants 
 
ND- No Activity detected.   
Domain PRODH P5CDH
Substrate Proline CoQ1 L-P5C
Km
(mM)
kcat
(sec-1)
kcat/Km
(M-1 sec-1)
Km
(µM)
kcat
(sec-1)
kcat/Km
(M-1 sec-1)
Km
(mM)
kcat
(sec-1)
kcat/Km
(M-1 sec-1)
WT
BjPutA
28.6  3.8 1.69  0.06 5.9 x 101
83.63  
13.41
1.59  0.09 1.9 x104 1.35  0.16 3.45  0.18 2.6 x 103
BjPutA 
R456M
ND ND ND ND ND ND 1.62  0.21 3.44  0.21 2.1 x 103
BjPutA 
C792A
60.1  10.1 1.58  0.09 2.6 x 101
103.01  
20.83
1.39  0.12 1.4 x 104 ND ND ND
BjPutA 1-
986
40.6  2.7 3.47  0.07 8.5 x 101
72.41  
4.96
3.54  0.08 4.9 x 104 1.13  0.13 3.26  0.16 2.88 x 103
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The P5CDH kinetic parameters of wild-type BjPutA (Km = 1.35 ± 0.16 mM L-P5C, kcat = 
3.45 ± 0.18 sec
-1
) and BjPutA 1-986 (Km = 1.13 ± 0.13 mM L-P5C, kcat = 3.26 ± 0.16  
sec
-1
) are nearly identical (Table 1). The R456M mutant exhibits P5CDH activity similar 
to that of wild-type BjPutA (Table 1). As anticipated, the C792A mutant has no P5CDH 
activity.  
Substrate channeling assays 
A common strategy to test for channeling is to evaluate whether there is a lag time 
in reaching steady-state formation of the final product in a coupled assay. Figure 4 shows 
the substrate proline being converted to the final product glutamate (reflected by 
concomitant NADH formation) via the coupled action of PRODH and P5CDH domains 
of BjPutA. With wild-type BjPutA, steady-state formation of NADH occurs without any 
apparent lag time. However, the progress curve can be fitted to equation 4.2 for a two-
enzyme model to yield a lag time of 10 sec. The near absence of a lag time in the 
approach to steady-state is indicative of substrate channeling. Fitting the reaction 
progress curve for the non-channeling enzyme pair C792A and R456M to equation 4.2 
estimates a lag time of 7.8 min. The lag time determined by extrapolation of the linear 
NADH formation rate is somewhat shorter at 5.3 min. In contrast to wild-type BjPutA, 
BjPutA 1-986 exhibits a noticeable lag time of about 2.5 min by extrapolating from the 
steady-state linear phase of the reaction. Fitting the progress curve to equation 4.2 yields 
a lag time of 2.4 min. The observation of a lag in NADH formation with BjPutA 1-986 
indicates that deletion of C-terminal residues 987-999 diminishes substrate channeling.   
However, the lag time is only 50% of the non-channeling control suggesting that to some 
extent substrate channeling is still occurring.  
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Figure 4- Transient time analysis of BjPutA and channeling variants. Colored solid 
lines represent the time-course of NADH formation for BjPutA, BjPutA 1-986 and non-
channeling mixed variants C792A and R456M using 40 mM proline, 0.1 mM CoQ1 and 
0.2 mM NAD
+
 as substrates and 0.18 µM of each enzyme. Colored dashed lines represent 
extrapolation of linear rate of NADH formation to the x-axis. The estimated lag time (x-
intercept) from the extrapolations are 2.5 min and 5.3 min for BjPutA 1-986 and non-
channeling mixed variants C792A and R456M,, respectively. The black dotted lines 
overlapping each trace of NADH formation are the fitting of the reaction progress curve 
with the two-enzyme model (equation 4.2). The estimated transient times from the fitting 
are 10 sec, 2.4 min, and 7.8 min for wild-type BjPutA, BjPutA 1-986 and mixed variants 
C792A and R456M, respectively.  
 
pH activity dependence of substrate channeling 
We next wanted to test the effect of pH on substrate channeling and explore the 
pH dependent hydrolysis of P5C as previously discussed. Channeling assays were 
performed for wild-type BjPutA, BjPutA 1-986 and the mixed variants (C792A and 
R456M) from pH 6-10.  Figure 5A shows the time-course of NADH formation using 40 
mM proline as the initial substrate for wild-type BjPutA. A plot of NADH formation  
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Figure 5- pH activity dependence of NADH formation. A) Time-course of 
NADH formation by wild-type BjPutA  pH 6-9.5. B) Plot of the steady-state linear rates 
of NADH formation versus pH for wild-type BjPutA, mutant 1-986, and mixed variants 
(C792A and R456M). 50 mM potassium phosphate, 25 mM borate and 25 mM bicine 
mixed buffer system was used to generate a pH range of 6 to 10. 
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versus pH (Figure 5B) shows that the rate of NADH formation reaches a maximum at pH 
6.5 and steadily declines with increased pH. BjPutA 1-986 shows an identical 
dependence on pH (Figure 5B). The mixed BjPutA mutants show a similar pH 
dependence as well except that NADH formation peaks at pH 7 (Figure 5B). The rates for 
NADH formation are similar for each BjPutA enzyme at pH 6.0 with 1.92 µM/min, 2.11 
µM/min and 2.0 µM/min for wild-type BjPutA, BjPutA 1-986 and mixed variants 
respectively. These rates decrease by 8-9 fold at pH 10.0. Next, the lag time for NADH 
formation was plotted as a function of pH (Figure 6).  
 
Figure 6- pH dependence of transient time in the BjPutA channeling reaction. 
Transient time is extrapolated from the linear rate of NADH formation and plotted 
against pH. The change in transient time is fitted to equation 4.4 using SigmaPlot 12 
(Systat Inc.). The solid line, dotted line and dashed line correspond to the fit for BjPutA, 
BjPutA 1-986 and mixed variants with pKa values of 8.64, 8.70 and 8.53 respectively.  
 
The lag time remains unchanged within the pH range 6 to 8 for wild-type BjPutA, 
BjPutA 1-986 and the mixed variants. Within this pH range, wild-type BjPutA exhibits 
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approximately no lag in NADH formation, whereas BjPutA 1-986 and mixed variants 
show lag times of about 2.5 min and 6 min, respectively. Above pH 8 there is a drastic 
increase in the lag time to an equal extent for all three enzymes. A plateau is reached 
above pH 9, with apparent lag times of 17-23 min for the different BjPutA enzymes. 
Figures 5 and 6 show that wild-type BjPutA, BjPutA 1-986, and the mixed variants 
exhibit similar pH profiles of NADH formation.  
Effect of pH on PRODH and P5CDH domains of BjPutA 
To further probe the factors influencing the pH dependence of NADH formation 
in BjPutA, we examined the effect of pH on the individual PRODH and P5CDH 
activities. The PRODH specific activity of wild-type BjPutA , BjPutA 1-986, and the 
mixed variants was measured at different pH values. These assays used 40 mM proline 
and 0.1 mM CoQ1 similar to the channeling assays shown in Figures 4 and 5 [4]. Figure 7 
shows the dependence of PRODH activity on pH.  
 
Figure 7- pH profile of PRODH specific activities. Specific activities of PRODH from 
BjPutA, BjPutA 1-986 and C792A measured by production of o-AB-P5C complex at 443 
nm. The pH profiles were fit to equation 4.1 in SigmaPlot 12 (Systat Inc.). The solid line, 
dotted line and dashed line correspond to the fit for BjPutA, BjPutA 1-986 and C792A 
with peak activity estimated at pH 8.07, 7.6 and 7.75 respectively. 
116 
 
 
 
A bell-shaped pH profile with peak activity at pH 8 was observed for each enzyme. Wild-
type BjPutA, BjPutA 1-986 and C792A reached maximal PRODH activities of 5.74, 6.56 
and 7.27 µM o-AB-P5C/min, respectively. The pH profiles are similar to that observed 
for monofunctional Put1p from S. cerevisiae (Chapter 2).  
The Km and specificity constant (kcat/Km) of P5CDH activity of wild-type BjPutA, 
BjPutA 1-986, and BjPutA mutant R456M were determined at different pH. For all three 
BjPutA enzymes, a plot of kcat/Km versus pH yields a bell-shaped curved with kcat/Km  
maximum at pH 7 (Figure 8A). At pH 9.0, kcat/Km decreases by > 10-fold to about 200 M
-
1
 sec
-1
 compared to 2600-3600 M
-1
 sec
-1
 at pH 7. The sharp decrease in kcat/Km at pH > 
7.0 may be attributed to less favorable P5C/GSA equilibrium or a change in substrate 
binding. A plot of Km versus pH (Figure 8B) shows that Km for P5C/GSA does not 
significantly increase until pH > 8.5 with Km values for P5C/GSA estimated above 10 
mM at pH 9.0 for wild-type BjPutA and R456M and, above 30 mM at pH 9.5 for BjPutA 
1-986.  
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Figure 8- pH profile of P5CDH kinetic parameters. A) Specificity constant (kcat/Km) 
for BjPutA, BjPutA 1-986 and R456M P5CDH domains plotted versus pH. The pH 
profiles were fit to equation 4.1 in SigmaPlot 12 (Systat Inc.). The solid line, dotted line 
and dashed line correspond to the fit for BjPutA, BjPutA 1-986 and R456M with peak 
activity estimated at pH 6.86, 6.89 and 6.75, respectively. B) Plot of Km (P5C/GSA mM) 
for P5CDH activity versus pH. Significant increase in Km was observed at pH > 8.5.   
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DISCUSSION 
 Truncation of C-terminal residues (987-999) in PutA from B. japonicum was 
expected to increase solvent accessibility to the substrate channel by creating an 
additional opening into the cavity between the PRODH and P5CDH active sites. Thus, it 
was hypothesized that the truncated BjPutA 1-986 mutant may partially leak the 
intermediate P5C/GSA into the bulk solvent. In previous studies on BjPutA [4], the 
appearance of the intermediate P5C in the bulk medium was studied using a trapping 
assay using o-AB. In the trapping assays inverted membrane vesicles from E. coli (putA
-
 
strain) [15] were used as terminal electron acceptor in the absence and presence of 0.2 
mM NAD
+
. From the results of these assays, 70% of the P5C/GSA was estimated to 
directly channel from PRODH to P5CDH in wild-type BjPutA [4]. Unlike wild-type 
BjPutA, BjPutA 1-986 does not exhibit turnover with inverted membrane vesicles (data 
not shown). The lack of functional PRODH activity with membrane vesicles suggests 
that residues 987-999 are also important for BjPutA membrane binding. Thus, residues 
987-99 appear not only to be important for forming the channel but also have a role in 
functional membrane binding. Because BjPutA 1-986 does not bind to membranes, it is 
not possible to directly compare the channeling efficiency of BjPutA 1-986 with wild-
type PutA. Transient time analysis shows that truncation of the C-terminal residues of 
BjPutA increases the time required to achieve steady-state formation of NADH. Steady-
state formation of NADH is reached at approximately 2.5 min for BjPutA 1-986, which is 
significantly longer than the ~ 10 sec lag time observed with wild-type BjPutA. These 
results indicate that P5C/GSA leaks into the bulk solvent in assays with BjPutA 1-986 
consistent with increased solvent access to the substrate channeling cavity as predicted by 
the BjPutA structure.  
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The equilibrium of the intermediates P5C and GSA is pH dependent with the 
open-chain GSA favored at pH < 6.6 [6]. It is not known where the obligate hydrolysis 
step occurs in BjPutA. Structural analysis of the P5CDH active site indicates that P5C 
and GSA can both bind to the active site. The observation that proline inhibits TtP5CDH 
(Chapter 2) suggests that P5C may bind at the P5CDH active site and that the hydrolysis 
step occurs in the active site. We hypothesized that the substrate channel may facilitate 
the P5C/GSA equilibrium by increasing the pKa of the pyrrolinium species above pH 6.6, 
making the hydrolysis of P5C to GSA more favorable at physiological pH conditions. 
Because BjPutA 1-986 was considered to have a more solvent exposed substrate channel, 
it was thought that the pH activity dependence of BjPutA and BjPutA 1-986 may be 
different. 
The pH profile of the substrate channeling reaction and the transient time, 
however, showed no significant differences between wild-type BjPutA, BjPutA 1-986, 
and the equimolar mixture of the BjPutA monofunctional variants. The peak activity for 
substrate channeling reaction was observed at pH 6.5-7.0 for the three different enzyme 
systems. The transient time to attain steady-state NADH formation remained unchanged 
between pH 6-8, a range in which the equilibrium of P5C/GSA is expected to be 
significantly altered by the pH environment. BjPutA 1-986 and the non-channeling mixed 
variants did exhibit lag times (2.5 min and 5.3 min, respectively), but the lag times did 
not appear to change until pH > 8.0. Interestingly, the transient time for wild-type 
BjPutA, BjPutA 1-986, and the mixed variants all showed the same pH dependence 
significant increased observed at pH > 8.0.  If the substrate channel was critical for 
facilitating the hydrolysis of P5C at a more physiological pH environment, then BjPutA 
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1-986 and the mixed variants would have shown significantly different pH activity 
dependences. The substrate channel cavity is expected to be more solvent exposed in 
BjPutA 1-986 and with the mixed variants P5C/GSA must equilibrate with the bulk 
solvent to form NADH. The similar pH profiles of wild-type BjPutA, BjPutA 1-986, and 
the mixed variants argue against the channel facilitating the P5C/GSA equilibrium and 
suggests that the hydrolysis of P5C occurs in the P5CDH active site.  
To investigate the pH effect on substrate channeling further, the pH activity 
dependence of the individual PRODH and P5CDH domains were assessed separately. 
The pH profile of PRODH activity for wild-type BjPutA, BjPutA 1-986, and BjPutA 
mutant C792A all show a bell-shaped curve with peak activity at pH 8.0. At this point it 
is not clear what step in the PRODH reaction is most influencing the pH profile that is 
observed for PRODH activity.  A straightforward experiment that could be performed 
would be to measure the rate of flavin reduction under single-turnover conditions at 
varying pH.  This would help dissect out the effect of pH on the substrate binding and 
chemical steps of the PRODH reaction. This experiment, however, was not pursued 
because of difficulties with BjPutA (20-40 µM concentration) precipitating at pH > 8.0.  
The activity of P5CDH for wild-type BjPutA, BjPutA 1-986, and BjPutA R456M 
was also significantly affected by pH (Figure 8 A) with peak activity at pH 7 for all three 
enzymes. pH can influence factors which are important for P5CDH catalysis such as 
hydrolysis of P5C to GSA, deprotonation of the active site cysteine and hydride transfer 
from GSA to NAD
+
 [16]. Because the pH dependence of NADH formation seems to 
correlate more closely with the pH activity profile of P5CDH activity, it appears that 
catalytic steps in the P5CDH active site have a greater influence on the pH dependence of 
121 
 
 
 
substrate channeling than the PRODH reaction.  Future experiments will need to dissect 
the different catalytic steps of the P5CDH reaction to provide more insights into the pH 
sensitive steps of P5CDH activity and the overall BjPutA substrate channeling reaction.  
  
122 
 
 
 
REFERENCES 
1. Krishnan, N. and D.F. Becker, Characterization of a bifunctional PutA 
homologue from Bradyrhizobium japonicum and identification of an active site 
residue that modulates proline reduction of the flavin adenine dinucleotide 
cofactor. Biochemistry, 2005. 44(25): p. 9130-9. 
2. Tanner, J.J., Structural biology of proline catabolism. Amino Acids, 2008. 35(4): 
p. 719-30. 
3. Adams, E. and L. Frank, Metabolism of proline and the hydroxyprolines. Annu 
Rev Biochem, 1980. 49: p. 1005-61. 
4. Srivastava, D., et al., Crystal structure of the bifunctional proline utilization A 
flavoenzyme from Bradyrhizobium japonicum. Proceedings of the National 
Academy of Sciences, 2010. 107(7): p. 2878-2883. 
5. DeLano, W.L., The PyMOL Molecular Graphics System. DeLano Scientific, San 
Carlos, CA, USA., 2002. 
6. Bearne, S.L. and R. Wolfenden, Glutamate gamma-semialdehyde as a natural 
transition state analogue inhibitor of Escherichia coli glucosamine-6-phosphate 
synthase. Biochemistry, 1995. 34(36): p. 11515-20. 
7. Williams, I. and L. Frank, Improved chemical synthesis and enzymatic assay of 
delta-1-pyrroline-5-carboxylic acid. Anal Biochem, 1975. 64(1): p. 85-97. 
8. Antharavally, B.S., et al., Quantitation of proteins using a dye-metal-based 
colorimetric protein assay. Anal Biochem, 2009. 385(2): p. 342-5. 
9. Grauschopf, U., A. Fritz, and R. Glockshuber, Mechanism of the electron transfer 
catalyst DsbB from Escherichia coli. Embo J, 2003. 22(14): p. 3503-13. 
10. Mezl, V.A. and W.E. Knox, Properties and analysis of a stable derivative of 
pyrroline-5-carboxylic acid for use in metabolic studies. Anal Biochem, 1976. 
74(2): p. 430-40. 
11. Meek, T.D., E.P. Garvey, and D.V. Santi, Purification and characterization of the 
bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-
resistant Leishmania tropica. Biochemistry, 1985. 24(3): p. 678-86. 
12. Becker, D.F. and E.A. Thomas, Redox properties of the PutA protein from 
Escherichia coli and the influence of the flavin redox state on PutA-DNA 
interactions. Biochemistry, 2001. 40(15): p. 4714-21. 
13. Moxley, M.A., J.J. Tanner, and D.F. Becker, Steady-state kinetic mechanism of 
the proline:ubiquinone oxidoreductase activity of proline utilization A (PutA) 
from Escherichia coli. Arch Biochem Biophys, 2011. 516(2): p. 113-20. 
14. Wanduragala, S., et al., Purification and characterization of Put1p from 
Saccharomyces cerevisiae. Arch Biochem Biophys, 2010. 498(2): p. 136-42. 
15. Brown, E.D. and J.M. Wood, Redesigned purification yields a fully functional 
PutA protein dimer from Escherichia coli. J Biol Chem, 1992. 267(18): p. 13086-
92. 
16. Loveridge, E.J. and R.K. Allemann, Effect of pH on hydride transfer by 
Escherichia coli dihydrofolate reductase. Chembiochem, 2011. 12(8): p. 1258-62. 
